\r\n\tRadiation monitoring deals with the sampling and measurement of different products found in different radiation pathways from the environment ending with consumption in humans. Gamma-spectroscopy is the main tool for measurement of these radiations.
\r\n
\r\n\tThe aim of this book is to investigate the radionuclide concentrations in the most consumable food products, air, water and soil. Particularly, it is essential to investigate the radiations level in the surroundings of a nuclear facility.
",isbn:null,printIsbn:"979-953-307-X-X",pdfIsbn:null,doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,isSalesforceBook:!1,hash:"f28404d284d64cf01d21820a3fc44c64",bookSignature:"Associate Prof. Muhammad Zubair",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11144.jpg",keywords:"Radioactivity Investigation, Aerosols, Water, Food Products, Health Effects, Tritium, Scintillation Counter, Alpha-Beta Radiation Monitoring, Gamma Spectroscopy, Radioactive Sampling, Environmental Effects, Activity Concentration",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"September 29th 2021",dateEndSecondStepPublish:"October 27th 2021",dateEndThirdStepPublish:"December 26th 2021",dateEndFourthStepPublish:"March 16th 2022",dateEndFifthStepPublish:"May 15th 2022",remainingDaysToSecondStep:"7 months",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"Associate Professor at the University of Sharjah, the United Arab Emirates whose interests include nuclear reactor safety, accident analysis, reliability, risk analysis, digital instrumentation and control, and radiation detection and measurements.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"320007",title:"Associate Prof.",name:"Muhammad",middleName:null,surname:"Zubair",slug:"muhammad-zubair",fullName:"Muhammad Zubair",profilePictureURL:"https://mts.intechopen.com/storage/users/320007/images/system/320007.png",biography:"Dr. Muhammad Zubair is an Associate Professor at the Department of Mechanical and Nuclear Engineering, University of Sharjah, United Arab Emirates. Prior to this role, Dr. Zubair worked as an assistant professor and graduate program coordinator at the University of Engineering and Technology Taxila, Pakistan.\nDr. Zubair’s interests include nuclear reactor safety, accident analysis, reliability and risk analysis, digital instrumentation and control, and radiation detection and measurements. He has a strong research background supported by publications in international journals, conferences, and book chapters. He is engaged in different research projects including one coordinated by the International Atomic Energy Agency (IAEA). He also serves as editor, associate editor, and technical committee member for international journals and conferences.",institutionString:"University of Sharjah",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"University of Sharjah",institutionURL:null,country:{name:"United Arab Emirates"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"20",title:"Physics",slug:"physics"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"440212",firstName:"Elena",lastName:"Vracaric",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/440212/images/20007_n.jpg",email:"elena@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"10384",title:"Practical Applications in Reliability Engineering",subtitle:null,isOpenForSubmission:!1,hash:"377d3c041a06cfcfc99bd906fdbbbf46",slug:"practical-applications-in-reliability-engineering",bookSignature:"Muhammad Zubair",coverURL:"https://cdn.intechopen.com/books/images_new/10384.jpg",editedByType:"Edited by",editors:[{id:"320007",title:"Associate Prof.",name:"Muhammad",surname:"Zubair",slug:"muhammad-zubair",fullName:"Muhammad Zubair"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8356",title:"Metastable, Spintronics Materials and Mechanics of Deformable Bodies",subtitle:"Recent Progress",isOpenForSubmission:!1,hash:"1550f1986ce9bcc0db87d407a8b47078",slug:"solid-state-physics-metastable-spintronics-materials-and-mechanics-of-deformable-bodies-recent-progress",bookSignature:"Subbarayan Sivasankaran, Pramoda Kumar Nayak and Ezgi Günay",coverURL:"https://cdn.intechopen.com/books/images_new/8356.jpg",editedByType:"Edited by",editors:[{id:"190989",title:"Dr.",name:"Subbarayan",surname:"Sivasankaran",slug:"subbarayan-sivasankaran",fullName:"Subbarayan Sivasankaran"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"57909",title:"Validation of Analytical Methods",doi:"10.5772/intechopen.72087",slug:"validation-of-analytical-methods",body:'
1. Introduction
Analytical method validation is an essential requirement to perform the chemical evaluation [1, 2, 3]. Method validation is a procedure of performing numerous assessments designed to verify that an analytical test system is suitable for its intended reason and is capable of providing beneficial and legitimate analytical data [4, 5, 6, 7, 8]. A validation examine includes testing multiple attributes of a method to determine that it may provide useful and valid facts whilst used robotically [9, 10, 11]. To accurately investigate method parameters, the validation test ought to consist of normal test conditions, which includes product excipients [11, 12, 13, 14]. Therefore, a method validation examine is product-specific.
2. Procedure
2.1. Parameters to be checked for method validation
Selectivity/Specificity
Precision
Accuracy
Linearity
Range
Stability
Limit of Detection (LOD) and Limit of Quantitation (LOQ)
2.1.1. Selectivity/specificity
Selectivity of an analytical method is its ability to measure accurately an analyte in the presence of interferences that may be expected to be present in the sample matrix.
Selectivity is checked by examining chromatographic blanks (from a sample that is known to contain no analyte) in the expected time window of the analyte peak. And the raw data for selectivity will be recorded in the raw data in approved formats.
2.1.2. Precision
Precision of a method is the degree of agreement among individual test results when the procedure is applied repeatedly to multiple samplings.
Precision is measured by injecting a series of standards or analyzing series of samples from multiple samplings from a homogeneous lot. From the measured standard deviation (SD) and Mean values, precision as relative standard deviation (% rsd) is calculated.
%rsdorCV=SDMean×100E1
The raw data for precision will be recorded in the approved format and the acceptance criteria for precision will be given in the respective study plan or amendment to the study plan.
OR
Precision can be also calculated by using Horwitz equation:
The acceptable percent of relative standard deviation results for precision may be based on the Horwitz equation, an exponential relationship between the among-laboratory relative standard deviation (RSDR) and Concentration (C): [15]
%RSDR=21−0.5logCE2
For estimation of repeatability (RSDr), is modified to:
%RSDr=%RSDR×0.67E3
The Horwitz curve has been empirically derived and has been proven to be more or less independent of analyte, matrix and method of evaluation over the concentration range C = 1 (100%) to C = 10−9 by the evaluation of vast numbers of method precision studies. The modified Horwitz values for repeatability CV given under may be used for guidance. If measured repeatability is outside those values, suggested explanation must be submitted for consideration. The details were presented in Table 1.
Percent of analyte
Proposed acceptable % RSDr (Horwitz value × 0.67)
100.00
1.340
50.00
1.490
20.00
1.710
10.00
1.900
5.00
2.100
2.00
2.410
1.00
2.680
0.25
3.300
Table 1.
Details of Horwitz values.
Note: The unmodified Horwitz equation is used as a criterion of acceptability for methods collaboratively tested by CIPAC.
2.1.3. Accuracy
The accuracy of an analytical method is the degree of agreement of test results generated by the method to the true value.
Accuracy is measured by spiking the sample matrix of interest with a known concentration of analyte standard and analyzing the sample using the “method being validated.” The procedure and calculation for Accuracy (as% recovery) will be varied from matrix to matrix and it will be given in respective study plan or amendment to the study plan.
2.1.4. Linearity
The linearity of an analytical method is its capability to elicit check consequences which might be at once, or with the aid of well described mathematical adjustments, proportional to the concentration of analytes in within a given range.
Linearity is determined by injecting a series of standards of stock solution/diluted stock solution using the solvent/mobile phase, at a minimum of five different concentrations in the range of 50–150% of the expected working range. The linearity graph will be plotted manually/using Microsoft Excel or software of the computer (Concentration vs. Peak Area Response) and which will be attached to respective study files.
2.1.5. Range
The range of an analytical method is the interval between the upper and lower levels that have been demonstrated to be determined with precision, accuracy and linearity using the set method. This range will be the concentration range in which the Linearity test is done.
2.1.6. Stability
Many analytes readily decompose prior to chromatography investigations, for example during the preparation of the sample solutions, during extraction, clean-up, phase transfer, and during storage of prepared vials. Under these circumstances, method development should investigate the stability of the analyte. Accuracy test takes care of stability. It is required to mention in the method how long a sample after extraction can be stored before final analysis, based on the duration taken for accuracy test.
2.1.7. Limit of detection and limit of quantitation
The term LOD is defined as the lowest concentration at which the instrument is able to detect but not quantify and the noise to signal ratio for LOD should be 1:3. The term LOQ is defined as the lowest concentration at which the instrument is able to detect and quantify. The noise to signal ratio for LOQ should be 1:10.
Determination of Limit of Detection (LOD) and Limit of Quantitation (LOQ) from Detector Linearity experiments (applicable to only instrument sensitivity).
LOD and LOQ values are calculated manually by taking Noise to signal ratio of a lowest/known concentration of linearity samples and it will be expressed in μg/ml or ppm. To calculate in %, values of LOD and LOQ will be multiplied by 100/lowest or known concentration of test item (mg/L) taken for analysis of that particular a.i. or impurity analysis.
Calculations of LOD and LOQ values for instrument sensitivity:
LODmg/L=3×NoiseSignal×Lowest concentration of the linearity samplesLOQmg/L=10×NoiseSignal×Lowest concentration of the linearity samples
2.1.8.1. Determination of limit of detection (LOD) and limit of quantitation (LOQ)
Prepare a series of standard solutions (minimum five concentrations covering working concentrations used for routine analysis) and analyze each solution minimum twice and record the instruments response.
Using the concentrations and corresponding instrument response, LOD and LOQ can be calculated as follows:
Let the linear regression equation be Y=a+bX.
Where, X and Y are the variables (data of two parameters). Generally, X is called the independent variable and Y, the dependent variable.
Take concentration on X-axis and instrument response on Y-axis.
“a” and “b” are the regression constants. Further, “a” is known as the intercept and “b,” the slope of the line.
Let (X1, Y1), (X2, Y2), (X3, Y3)…(Xn, Yn) be the set of values required to be fit in the linear equation.
iii. Calculate the slope “b,” and intercept “a” as given below:
b=∑xy∑xx
a=Y¯−bX¯
b. Method of calculation r (correlation coefficient)
r=∑xy∑xx.∑yy
c. Method of calculation standard deviation for “a” and “b”
The standard deviation of the individual deviations of measured values in Y, above and below the linear line (fitted line) is:
Sy.x=∑yy−∑xy2/∑xxn−2
From this, the standard deviation for “a” and “b” are calculated.
Standard deviation
for “a,” represented = Sy.x∑X2n∑xx
as Sa
Standard deviation.
For “b,” represented = Sy.x1n∑xx
as Sb
2.1.8.2. Application of a, b, and Sa to obtain limit of detection and limit of quantitation
When Sa is obtained for a linear calibration line, then it provides a clear information on the standard deviation of the “Blank” (or Control) response from the instruments.
The LOD and LOQ can be worked out, as given below:
LOD=a+3SabLOQ=a+10Sab
Note:
The above calculations can be programmed in a computer but before every use, the computer program must be validated using the example given in section
The above procedure can also be used for obtaining LOD and LOQ of the method from recovery test results by taking fortified concentration on X-axis and obtained concentrations on Y-axis.
3. Example
In this example, the linear regression equation is employed to find out the extent of linear response of an Detector to a reference analytical standard in the concentration range of about 0.2–3.0 ppm.
Each of these working standards is injected thrice (1 μl per injection), and the peak area counts corresponding to the active ingredient peak are given below.
From the peak areas corresponding to each concentration level, the mean, standard deviation (SD) and coefficient of variation (%CV) are also calculated. The details were presented in Table 2.
Conc. of standard solution (μg/ml)
Peak area
Mean
SD (n − 1)
%CV
1
2
3
0.1956
32,827
33,299
32,731
32,952
304
0.923
0.4890
87,783
88,480
87,446
87,903
527
0.600
0.9780
176,037
174,675
177,203
175,972
1265
0.719
1.467
246,212
250,786
246,849
247,949
2477
0.999
1.956
319,143
319,615
315,316
318,025
2358
0.741
2.934
415,059
410,773
418,407
414,746
3827
0.923
Table 2.
Calculation details of mean, SD, and %CV.
%CV = SD × 100/Mean: The coefficient of variation (CV) shows that the Injection variation is less than 1%.
Fitting the data of concentration of standard solution and mean detector response (peak area counts) in a linear equation
Let the equation be Y=a+bX.
Where, Y = Mean peak area counts and X = Concentration of standard solution, μg/ml.
Note: Assay procedures vary from highly exacting analytical determinations to subjective evaluations of attributes. Therefore different test methods require different validation schemes.
Category I
Analytical methods for quantitation of major excipients and/or active ingredients, and preservatives in finished goods.
Category II
Analytical methods for determination of impurities or degradation compounds in finished goods. These methods include quantitative assays and limit tests, titrimetric and bacterial endotoxin tests.
Category III
Analytical methods for determination of performance characteristics, e.g., sterility testing, dissolution and drug release for pharmaceutical products.
Data Elements Required for Assay Validation.
Details of required validation parameters of assay presented in Table 4.
Analytical validation data playing a fundamental role in pharmaceutical industry, pesticide industry for releasing the economic batch and long term stability information consequently, the records must be produced to suited regulatory authority requirements.
\n',keywords:"method validation, accuracy, precision, linearity, LOD, LOQ",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/57909.pdf",chapterXML:"https://mts.intechopen.com/source/xml/57909.xml",downloadPdfUrl:"/chapter/pdf-download/57909",previewPdfUrl:"/chapter/pdf-preview/57909",totalDownloads:6764,totalViews:2386,totalCrossrefCites:12,totalDimensionsCites:19,totalAltmetricsMentions:1,impactScore:7,impactScorePercentile:96,impactScoreQuartile:4,hasAltmetrics:1,dateSubmitted:"August 30th 2017",dateReviewed:"October 31st 2017",datePrePublished:null,datePublished:"April 25th 2018",dateFinished:"November 30th 2017",readingETA:"0",abstract:"Method validation is a key element in the establishment of reference methods and within the assessment of a laboratory’s competence in generating dependable analytical records. Validation has been placed within the context of the procedure, generating chemical data. Analytical method validation, thinking about the maximum relevant processes for checking the best parameters of analytical methods, using numerous relevant overall performance indicators inclusive of selectivity, specificity, accuracy, precision, linearity, range, limit of detection (LOD), limit of quantification (LOQ), ruggedness, and robustness are severely discussed in an effort to prevent their misguided utilization and ensure scientific correctness and consistency among publications.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/57909",risUrl:"/chapter/ris/57909",book:{id:"6379",slug:"calibration-and-validation-of-analytical-methods-a-sampling-of-current-approaches"},signatures:"Tentu Nageswara Rao",authors:[{id:"220824",title:"Dr.",name:"Tentu",middleName:null,surname:"Nageswara Rao",fullName:"Tentu Nageswara Rao",slug:"tentu-nageswara-rao",email:"tentu6581@rediffmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Procedure",level:"1"},{id:"sec_2_2",title:"2.1. Parameters to be checked for method validation",level:"2"},{id:"sec_2_3",title:"2.1.1. Selectivity/specificity",level:"3"},{id:"sec_3_3",title:"Table 1.",level:"3"},{id:"sec_4_3",title:"2.1.3. Accuracy",level:"3"},{id:"sec_5_3",title:"2.1.4. Linearity",level:"3"},{id:"sec_6_3",title:"2.1.5. Range",level:"3"},{id:"sec_7_3",title:"2.1.6. Stability",level:"3"},{id:"sec_8_3",title:"2.1.7. Limit of detection and limit of quantitation",level:"3"},{id:"sec_9_3",title:"2.1.8. Mathematical derivations",level:"3"},{id:"sec_9_4",title:"2.1.8.1. Determination of limit of detection (LOD) and limit of quantitation (LOQ)",level:"4"},{id:"sec_10_4",title:"2.1.8.2. Application of a, b, and Sa to obtain limit of detection and limit of quantitation",level:"4"},{id:"sec_14",title:"3. Example",level:"1"},{id:"sec_15",title:"4. Conclusions",level:"1"}],chapterReferences:[{id:"B1",body:'Validation of analytical procedure: Methodology Q2B. In: ICH Harmonized Tripartite Guidelines. Geneva, Switzerland. 1996. pp. 1-8'},{id:"B2",body:'CIPAC Document No. 3807—Guidelines on method Validation to be performed in sup- port of analytical methods for agrochemical Formulations, cipac.org on 28 July 2003'},{id:"B3",body:'International Standard ISO 5725. 1986. Precision of test methods—Repeatability and reproducibility'},{id:"B4",body:'ISO standard 11095. 1996. Linear calibration using reference material'},{id:"B5",body:'Horwitz W. Evaluation of analytical methods used for regulation of foods and drugs. Analytical Chemistry. 1982;54(1):67A-76A. DOI: 10.1021/AC00238A765'},{id:"B6",body:'Thompson M, Ellison SLR, Wood R. Harmonised guidelines for single laboratory validation of method of analysis. Pure and Applied Chemistry. 2008;74(5):835-855'},{id:"B7",body:'European Commission. Annex 15. EU guide to good manufacturing practice: Qualification and validation. 2010;4:1–10'},{id:"B8",body:'Ravichandran V, Shalini S, Sundram KM, Rajak H. Validation of analytical methods—Strategies & importance. International Journal of Pharmacy and Pharmaceutical Sciences. 2010;2(3):340-345'},{id:"B9",body:'Tangri P, Rawat PS, Jakhmola V. Validation: A critical parameter for quality control of pharmaceuticals. Journal of Drug Delivery & Therapeutics. 2012;2(3):34-40'},{id:"B10",body:'Sharma A, Sharma R. Validation of analytical procedures: A comparison of ICH Vs Pharmacopoiea (USP) Vs FDA. International Research Journal of Pharmacy. 2012;3(6):39-42'},{id:"B11",body:'Lambert J. Validation guidelines for pharmaceutical dosage forms. Health Canada Health Products and Food Branch Inspectorate. 2004;26:7-15'},{id:"B12",body:'Prabh SS, Gagan S. Analytical method development and validation. Journal of Pharmacy Research. 2011;4(7):2330-2332'},{id:"B13",body:'Ramamurthy M, Sarvanakumar K. Pharmaceutical validation. The Eastern Pharmacist. 1997;476:45-47'},{id:"B14",body:'Agalloco J. Validation: An unconventional review and reinvention. PDA. J. Pharm Sci Tech. 1995;49:175-179'},{id:"B15",body:'INRA Quality Policy and Quality Guidelines for the Research and Experimental Units. 2013'},{id:"B16",body:'Haider I. Section VAL 1100.00. In: Validation Standard Operating Procedures. A Step by Step Guide for Achieving Compliance in the Pharmaceutical Medical Device and BiotechIndustries. Boca Raton: CRC Press LLC; 2001'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Tentu Nageswara Rao",address:"tentu6581@rediffmail.com",affiliation:'
Department of Chemistry, Krishna University, Machilipatnam, Andhra Pradesh, India
'}],corrections:null},book:{id:"6379",type:"book",title:"Calibration and Validation of Analytical Methods",subtitle:"A Sampling of Current Approaches",fullTitle:"Calibration and Validation of Analytical Methods - A Sampling of Current Approaches",slug:"calibration-and-validation-of-analytical-methods-a-sampling-of-current-approaches",publishedDate:"April 25th 2018",bookSignature:"Mark T. Stauffer",coverURL:"https://cdn.intechopen.com/books/images_new/6379.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-78923-085-7",printIsbn:"978-1-78923-084-0",pdfIsbn:"978-1-83881-442-7",reviewType:"peer-reviewed",numberOfWosCitations:49,isAvailableForWebshopOrdering:!0,editors:[{id:"97565",title:"Dr.",name:"Mark",middleName:"Thomas",surname:"Stauffer",slug:"mark-stauffer",fullName:"Mark Stauffer"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"481"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"59895",type:"chapter",title:"Introductory Chapter: The Many Faces of Calibration and Validation in Analytical Methodology in the Present Day",slug:"introductory-chapter-the-many-faces-of-calibration-and-validation-in-analytical-methodology-in-the-p",totalDownloads:2813,totalCrossrefCites:0,signatures:"Mark T. Stauffer",reviewType:"peer-reviewed",authors:[{id:"97565",title:"Dr.",name:"Mark",middleName:"Thomas",surname:"Stauffer",fullName:"Mark Stauffer",slug:"mark-stauffer"}]},{id:"58230",type:"chapter",title:"Analytical Calibrations: Schemes, Manuals, and Metrological Deliberations",slug:"analytical-calibrations-schemes-manuals-and-metrological-deliberations",totalDownloads:1376,totalCrossrefCites:1,signatures:"Marwa S. El-Azazy",reviewType:"peer-reviewed",authors:[{id:"198210",title:"Dr.",name:"Marwa",middleName:"S.",surname:"El-Azazy",fullName:"Marwa El-Azazy",slug:"marwa-el-azazy"}]},{id:"58394",type:"chapter",title:"Multivariate Calibration for the Development of Vibrational Spectroscopic Methods",slug:"multivariate-calibration-for-the-development-of-vibrational-spectroscopic-methods",totalDownloads:1346,totalCrossrefCites:1,signatures:"Ioan Tomuta, Alina Porfire, Tibor Casian and Alexandru Gavan",reviewType:"peer-reviewed",authors:[{id:"188989",title:"Prof.",name:"Ioan",middleName:null,surname:"Tomuta",fullName:"Ioan Tomuta",slug:"ioan-tomuta"},{id:"202435",title:"Dr.",name:"Alina",middleName:null,surname:"Porfire",fullName:"Alina Porfire",slug:"alina-porfire"},{id:"214519",title:"Mr.",name:"Tibor",middleName:null,surname:"Casian",fullName:"Tibor Casian",slug:"tibor-casian"},{id:"214520",title:"Mr.",name:"Alexandru",middleName:null,surname:"Gavan",fullName:"Alexandru Gavan",slug:"alexandru-gavan"}]},{id:"60447",type:"chapter",title:"Internal Standards for Absolute Quantification of Large Molecules (Proteins) from Biological Matrices by LC-MS/MS",slug:"internal-standards-for-absolute-quantification-of-large-molecules-proteins-from-biological-matrices-",totalDownloads:1490,totalCrossrefCites:1,signatures:"Morse Faria and Matthew S. Halquist",reviewType:"peer-reviewed",authors:[{id:"216265",title:"Dr.",name:"Matthew",middleName:null,surname:"Halquist",fullName:"Matthew Halquist",slug:"matthew-halquist"},{id:"216266",title:"Dr.",name:"Morse",middleName:null,surname:"Faria",fullName:"Morse Faria",slug:"morse-faria"}]},{id:"58688",type:"chapter",title:"Calibration Methods of Laser-Induced Breakdown Spectroscopy",slug:"calibration-methods-of-laser-induced-breakdown-spectroscopy",totalDownloads:1625,totalCrossrefCites:3,signatures:"Hongbo Fu, Junwei Jia, Huadong Wang, Zhibo Ni and Fengzhong\nDong",reviewType:"peer-reviewed",authors:[{id:"69003",title:"Prof.",name:"Fengzhong",middleName:null,surname:"Dong",fullName:"Fengzhong Dong",slug:"fengzhong-dong"},{id:"235868",title:"Dr.",name:"Hongbo",middleName:null,surname:"Fu",fullName:"Hongbo Fu",slug:"hongbo-fu"},{id:"235869",title:"Mr.",name:"Junwei",middleName:null,surname:"Jia",fullName:"Junwei Jia",slug:"junwei-jia"},{id:"235870",title:"Ph.D. Student",name:"Huadong",middleName:null,surname:"Wang",fullName:"Huadong Wang",slug:"huadong-wang"},{id:"235873",title:"Dr.",name:"Zhibo",middleName:null,surname:"Ni",fullName:"Zhibo Ni",slug:"zhibo-ni"}]},{id:"58596",type:"chapter",title:"Linearity of Calibration Curves for Analytical Methods: A Review of Criteria for Assessment of Method Reliability",slug:"linearity-of-calibration-curves-for-analytical-methods-a-review-of-criteria-for-assessment-of-method",totalDownloads:7839,totalCrossrefCites:17,signatures:"Seyed Mojtaba Moosavi and Sussan Ghassabian",reviewType:"peer-reviewed",authors:[{id:"216099",title:"Dr.",name:"Sussan",middleName:null,surname:"Ghassabian",fullName:"Sussan Ghassabian",slug:"sussan-ghassabian"},{id:"216101",title:"Mr.",name:"Seyed Mojtaba",middleName:null,surname:"Moosavi",fullName:"Seyed Mojtaba Moosavi",slug:"seyed-mojtaba-moosavi"}]},{id:"57909",type:"chapter",title:"Validation of Analytical Methods",slug:"validation-of-analytical-methods",totalDownloads:6764,totalCrossrefCites:12,signatures:"Tentu Nageswara Rao",reviewType:"peer-reviewed",authors:[{id:"220824",title:"Dr.",name:"Tentu",middleName:null,surname:"Nageswara Rao",fullName:"Tentu Nageswara Rao",slug:"tentu-nageswara-rao"}]},{id:"57781",type:"chapter",title:"Method Validation Approaches for Pharmaceutical Assessments – Highlights with High Performance Thin Layer Chromatographic (HPTLC) Techniques",slug:"method-validation-approaches-for-pharmaceutical-assessments-highlights-with-high-performance-thin-la",totalDownloads:1260,totalCrossrefCites:1,signatures:"David Jenkins, Cherif Diallo, Ed Bethea, Eliangiringa Kaale and\nThomas Layloff",reviewType:"peer-reviewed",authors:[{id:"215717",title:"Ph.D.",name:"David",middleName:null,surname:"Jenkins",fullName:"David Jenkins",slug:"david-jenkins"},{id:"216020",title:"Dr.",name:"Cherif",middleName:null,surname:"Diallo",fullName:"Cherif Diallo",slug:"cherif-diallo"},{id:"216021",title:"Mr.",name:"Ed",middleName:null,surname:"Bethea",fullName:"Ed Bethea",slug:"ed-bethea"},{id:"216024",title:"Prof.",name:"Eliangiringa",middleName:null,surname:"Kaale",fullName:"Eliangiringa Kaale",slug:"eliangiringa-kaale"},{id:"216026",title:"Dr.",name:"Thomas",middleName:null,surname:"Layloff",fullName:"Thomas Layloff",slug:"thomas-layloff"}]}]},relatedBooks:[{type:"book",id:"5283",title:"Applications of Molecular Spectroscopy to Current Research in the Chemical and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5d879e015ea226a3cf4633c0a187c830",slug:"applications-of-molecular-spectroscopy-to-current-research-in-the-chemical-and-biological-sciences",bookSignature:"Mark T. Stauffer",coverURL:"https://cdn.intechopen.com/books/images_new/5283.jpg",editedByType:"Edited by",editors:[{id:"97565",title:"Dr.",name:"Mark",surname:"Stauffer",slug:"mark-stauffer",fullName:"Mark Stauffer"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"52212",title:"Fourier Transform Infrared and Raman Characterization of Silica-Based Materials",slug:"fourier-transform-infrared-and-raman-characterization-of-silica-based-materials",signatures:"Larissa Brentano Capeletti and João Henrique Zimnoch",authors:[{id:"178200",title:"Prof.",name:"Joao Henrique",middleName:null,surname:"Zimnoch Dos Santos",fullName:"Joao Henrique Zimnoch Dos Santos",slug:"joao-henrique-zimnoch-dos-santos"},{id:"186947",title:"Dr.",name:"Larissa",middleName:null,surname:"Brentano Capeletti",fullName:"Larissa Brentano Capeletti",slug:"larissa-brentano-capeletti"}]},{id:"51575",title:"Investigations of Phonons in Zinc Blende and Wurtzite by Raman Spectroscopy",slug:"investigations-of-phonons-in-zinc-blende-and-wurtzite-by-raman-spectroscopy",signatures:"Lin Sun, Lingcong Shi and Chunrui Wang",authors:[{id:"181895",title:"Prof.",name:"Chunrui",middleName:null,surname:"Wang",fullName:"Chunrui Wang",slug:"chunrui-wang"},{id:"183089",title:"Mr.",name:"Lin",middleName:null,surname:"Sun",fullName:"Lin Sun",slug:"lin-sun"},{id:"183090",title:"Mr.",name:"Lingcong",middleName:null,surname:"Shi",fullName:"Lingcong Shi",slug:"lingcong-shi"}]},{id:"51682",title:"Structural Characterization of Lithium Niobate Nanoparticles Prepared by the Sol-Gel Process, Using X-Ray and Raman Spectroscopy and Scanning Electron Microscopy",slug:"structural-characterization-of-lithium-niobate-nanoparticles-prepared-by-the-sol-gel-process-using-x",signatures:"Pedro R.S. Prezas and Manuel P.F. Graça",authors:[{id:"182217",title:"Ph.D. Student",name:"Pedro",middleName:null,surname:"Prezas",fullName:"Pedro Prezas",slug:"pedro-prezas"}]},{id:"51789",title:"Raman Spectroscopy, a Useful Tool to Study Nuclear Materials",slug:"raman-spectroscopy-a-useful-tool-to-study-nuclear-materials",signatures:"Laura J. Bonales, Jone M. Elorrieta, Álvaro Lobato and Joaquin\nCobos",authors:[{id:"182438",title:"Dr.",name:"Laura",middleName:"J.",surname:"Bonales",fullName:"Laura Bonales",slug:"laura-bonales"}]},{id:"51739",title:"Infrared Spectra and Density Functional Theoretical Calculation of Transition Metal Oxide Reaction with Monochloromethane",slug:"infrared-spectra-and-density-functional-theoretical-calculation-of-transition-metal-oxide-reaction-w",signatures:"Yanying Zhao, Xin Liu and Shuang Meng",authors:[{id:"182488",title:"Dr.",name:"Yanying",middleName:null,surname:"Zhao",fullName:"Yanying Zhao",slug:"yanying-zhao"},{id:"187392",title:"BSc.",name:"Xin",middleName:null,surname:"Liu",fullName:"Xin Liu",slug:"xin-liu"},{id:"187393",title:"BSc.",name:"Shuang",middleName:null,surname:"Meng",fullName:"Shuang Meng",slug:"shuang-meng"}]},{id:"50692",title:"Vibrational and Electronic Structure, Electron-Electron and Electron-Phonon Interactions in Organic Conductors Investigated by Optical Spectroscopy",slug:"vibrational-and-electronic-structure-electron-electron-and-electron-phonon-interactions-in-organic-c",signatures:"Andrzej Łapiński",authors:[{id:"181863",title:"Dr.",name:"Andrzej",middleName:null,surname:"Łapiński",fullName:"Andrzej Łapiński",slug:"andrzej-lapinski"}]},{id:"52140",title:"Infrared and Raman Spectroscopic Characterization of Porphyrin and its Derivatives",slug:"infrared-and-raman-spectroscopic-characterization-of-porphyrin-and-its-derivatives",signatures:"Metin Aydin and Daniel L. Akins",authors:[{id:"27070",title:"Prof.",name:"Metin",middleName:null,surname:"Aydin",fullName:"Metin Aydin",slug:"metin-aydin"},{id:"51926",title:"Prof.",name:"Daniel",middleName:"L.",surname:"Akins",fullName:"Daniel Akins",slug:"daniel-akins"}]},{id:"52018",title:"Novel Pressure-Induced Molecular Transformations Probed by In Situ Vibrational Spectroscopy",slug:"novel-pressure-induced-molecular-transformations-probed-by-in-situ-vibrational-spectroscopy",signatures:"Yang Song",authors:[{id:"27204",title:"Prof.",name:"Yang",middleName:null,surname:"Song",fullName:"Yang Song",slug:"yang-song"}]},{id:"52288",title:"Conformational Analysis of Molecules: Combined Vibrational Spectroscopy and Density Functional Theory Study",slug:"conformational-analysis-of-molecules-combined-vibrational-spectroscopy-and-density-functional-theory",signatures:"Partha P. Kundu and Chandrabhas Narayana",authors:[{id:"150767",title:"Dr.",name:"Chandrabhas",middleName:null,surname:"Narayana",fullName:"Chandrabhas Narayana",slug:"chandrabhas-narayana"},{id:"183330",title:"Dr.",name:"Partha",middleName:null,surname:"Kundu",fullName:"Partha Kundu",slug:"partha-kundu"}]},{id:"51755",title:"Geometric and Electronic Properties of Porphyrin and its Derivatives",slug:"geometric-and-electronic-properties-of-porphyrin-and-its-derivatives",signatures:"Metin Aydin and Daniel L. Akins",authors:[{id:"27070",title:"Prof.",name:"Metin",middleName:null,surname:"Aydin",fullName:"Metin Aydin",slug:"metin-aydin"}]},{id:"51767",title:"Applications of Molecular Spectroscopic Methods to the Elucidation of Lignin Structure",slug:"applications-of-molecular-spectroscopic-methods-to-the-elucidation-of-lignin-structure",signatures:"Tingting You and Feng Xu",authors:[{id:"174103",title:"Prof.",name:"Feng",middleName:null,surname:"Xu",fullName:"Feng Xu",slug:"feng-xu"},{id:"182550",title:"Dr.",name:"Tingting",middleName:null,surname:"You",fullName:"Tingting You",slug:"tingting-you"}]},{id:"50766",title:"Using Fluorescence Spectroscopy to Diagnose Breast Cancer",slug:"using-fluorescence-spectroscopy-to-diagnose-breast-cancer",signatures:"Tatjana Dramićanin and Miroslav Dramićanin",authors:[{id:"183261",title:"Prof.",name:"Miroslav",middleName:null,surname:"Dramicanin",fullName:"Miroslav Dramicanin",slug:"miroslav-dramicanin"},{id:"183280",title:"Dr.",name:"Tatjana",middleName:null,surname:"Dramicanin",fullName:"Tatjana Dramicanin",slug:"tatjana-dramicanin"}]},{id:"52309",title:"Applications of 1H Nuclear Magnetic Resonance Spectroscopy in Clinical Microbiology",slug:"applications-of-1h-nuclear-magnetic-resonance-spectroscopy-in-clinical-microbiology",signatures:"Lara García‐Álvarez, Jesús H. Busto, Jesús M. Peregrina, Alberto\nAvenoza and José Antonio Oteo",authors:[{id:"64887",title:"Dr.",name:"José A.",middleName:null,surname:"Oteo",fullName:"José A. Oteo",slug:"jose-a.-oteo"},{id:"186761",title:"BSc.",name:"Lara",middleName:null,surname:"García-Álvarez",fullName:"Lara García-Álvarez",slug:"lara-garcia-alvarez"},{id:"186762",title:"Dr.",name:"Jesús H.",middleName:null,surname:"Busto",fullName:"Jesús H. Busto",slug:"jesus-h.-busto"},{id:"186763",title:"Prof.",name:"Jesús M.",middleName:null,surname:"Peregrina",fullName:"Jesús M. Peregrina",slug:"jesus-m.-peregrina"},{id:"186764",title:"Prof.",name:"Alberto A",middleName:null,surname:"Avenoza",fullName:"Alberto A Avenoza",slug:"alberto-a-avenoza"}]},{id:"52007",title:"Improving Food Safety by Using One- and Two-Photon- Induced Fluorescence Spectroscopy for the Detection of Mycotoxins",slug:"improving-food-safety-by-using-one-and-two-photon-induced-fluorescence-spectroscopy-for-the-detectio",signatures:"Lien Smeesters, Wendy Meulebroeck and Hugo Thienpont",authors:[{id:"182428",title:"Ph.D.",name:"Lien",middleName:null,surname:"Smeesters",fullName:"Lien Smeesters",slug:"lien-smeesters"},{id:"183268",title:"Prof.",name:"Wendy",middleName:null,surname:"Meulebroeck",fullName:"Wendy Meulebroeck",slug:"wendy-meulebroeck"},{id:"183270",title:"Prof.",name:"Hugo",middleName:null,surname:"Thienpont",fullName:"Hugo Thienpont",slug:"hugo-thienpont"}]},{id:"51985",title:"Microprobing Structural Architecture Using Mid-Infrared Vibrational Molecular Spectroscopy",slug:"microprobing-structural-architecture-using-mid-infrared-vibrational-molecular-spectroscopy",signatures:"Yuguang Ying and Peiqiang Yu",authors:[{id:"12680",title:"Prof.",name:"Peiqiang",middleName:null,surname:"Yu",fullName:"Peiqiang Yu",slug:"peiqiang-yu"}]},{id:"51194",title:"Fluorescence Spectroscopy for the Analysis of Spirit Drinks",slug:"fluorescence-spectroscopy-for-the-analysis-of-spirit-drinks",signatures:"Jana Sádecká, Veronika Uríčková and Michaela Jakubíková",authors:[{id:"183253",title:"Associate Prof.",name:"Jana",middleName:null,surname:"Sádecká",fullName:"Jana Sádecká",slug:"jana-sadecka"},{id:"183378",title:"Dr.",name:"Michaela",middleName:null,surname:"Jakubíková",fullName:"Michaela Jakubíková",slug:"michaela-jakubikova"},{id:"183379",title:"Dr.",name:"Veronika",middleName:null,surname:"Uríčková",fullName:"Veronika Uríčková",slug:"veronika-urickova"}]},{id:"50963",title:"Laser Spectroscopy in Hollow‐Core Fibers: Principles and Applications",slug:"laser-spectroscopy-in-hollow-core-fibers-principles-and-applications",signatures:"Philip G. Westergaard",authors:[{id:"183048",title:"Dr.",name:"Philip",middleName:null,surname:"Westergaard",fullName:"Philip Westergaard",slug:"philip-westergaard"}]},{id:"51493",title:"Enhanced Molecular Spectroscopy via Localized Surface Plasmon Resonance",slug:"enhanced-molecular-spectroscopy-via-localized-surface-plasmon-resonance",signatures:"Lu Sun, Ping Chen and Lie Lin",authors:[{id:"55520",title:"Prof.",name:"Ping",middleName:null,surname:"Chen",fullName:"Ping Chen",slug:"ping-chen"},{id:"61965",title:"Prof.",name:"Lie",middleName:null,surname:"Lin",fullName:"Lie Lin",slug:"lie-lin"},{id:"183365",title:"Dr.",name:"Lu",middleName:null,surname:"Sun",fullName:"Lu Sun",slug:"lu-sun"}]},{id:"51969",title:"Using Raman Spectroscopy for Characterization of Aqueous Media and Quantification of Species in Aqueous Solution",slug:"using-raman-spectroscopy-for-characterization-of-aqueous-media-and-quantification-of-species-in-aque",signatures:"Ivana Durickovic",authors:[{id:"183018",title:"Dr.",name:"Ivana",middleName:null,surname:"Durickovic",fullName:"Ivana Durickovic",slug:"ivana-durickovic"}]}]}],publishedBooks:[{type:"book",id:"2114",title:"Advanced Gas Chromatography",subtitle:"Progress in Agricultural, Biomedical and Industrial Applications",isOpenForSubmission:!1,hash:"039ef2e529d905397d4775625fcc9ef5",slug:"advanced-gas-chromatography-progress-in-agricultural-biomedical-and-industrial-applications",bookSignature:"Mustafa Ali Mohd",coverURL:"https://cdn.intechopen.com/books/images_new/2114.jpg",editedByType:"Edited by",editors:[{id:"108777",title:"Dr.",name:"Mustafa",surname:"Ali Mohd",slug:"mustafa-ali-mohd",fullName:"Mustafa Ali Mohd"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2248",title:"Applications of Gas Chromatography",subtitle:null,isOpenForSubmission:!1,hash:"a085440aee8d8c2c09b577246ede87ad",slug:"applications-of-gas-chromatography",bookSignature:"Reza Davarnejad and Mahboubeh Jafarkhani",coverURL:"https://cdn.intechopen.com/books/images_new/2248.jpg",editedByType:"Edited by",editors:[{id:"88069",title:"Associate Prof.",name:"Reza",surname:"Davarnejad",slug:"reza-davarnejad",fullName:"Reza Davarnejad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2327",title:"Chromatography",subtitle:"The Most Versatile Method of Chemical Analysis",isOpenForSubmission:!1,hash:"730549acc4ff27929bb106ba63661172",slug:"chromatography-the-most-versatile-method-of-chemical-analysis",bookSignature:"Leonardo de Azevedo Calderon",coverURL:"https://cdn.intechopen.com/books/images_new/2327.jpg",editedByType:"Edited by",editors:[{id:"177382",title:"Dr.",name:"Leonardo de Azevedo",surname:"Calderon",slug:"leonardo-de-azevedo-calderon",fullName:"Leonardo de Azevedo Calderon"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6125",title:"Calorimetry",subtitle:"Design, Theory and Applications in Porous Solids",isOpenForSubmission:!1,hash:"7057998c2bd96e7ee749cccf401a0464",slug:"calorimetry-design-theory-and-applications-in-porous-solids",bookSignature:"Juan Carlos Moreno-Piraján",coverURL:"https://cdn.intechopen.com/books/images_new/6125.jpg",editedByType:"Edited by",editors:[{id:"14015",title:"Dr.",name:"Juan Carlos",surname:"Moreno Piraján",slug:"juan-carlos-moreno-pirajan",fullName:"Juan Carlos Moreno Piraján"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6379",title:"Calibration and Validation of Analytical Methods",subtitle:"A Sampling of Current Approaches",isOpenForSubmission:!1,hash:"b2accb70a1680c9d57a55484a1852a10",slug:"calibration-and-validation-of-analytical-methods-a-sampling-of-current-approaches",bookSignature:"Mark T. Stauffer",coverURL:"https://cdn.intechopen.com/books/images_new/6379.jpg",editedByType:"Edited by",editors:[{id:"97565",title:"Dr.",name:"Mark",surname:"Stauffer",slug:"mark-stauffer",fullName:"Mark Stauffer"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[{type:"book",id:"6379",title:"Calibration and Validation of Analytical Methods",subtitle:"A Sampling of Current Approaches",isOpenForSubmission:!1,hash:"b2accb70a1680c9d57a55484a1852a10",slug:"calibration-and-validation-of-analytical-methods-a-sampling-of-current-approaches",bookSignature:"Mark T. Stauffer",coverURL:"https://cdn.intechopen.com/books/images_new/6379.jpg",editedByType:"Edited by",editors:[{id:"97565",title:"Dr.",name:"Mark",surname:"Stauffer",slug:"mark-stauffer",fullName:"Mark Stauffer"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},onlineFirst:{chapter:{type:"chapter",id:"77033",title:"Adverse Drug Reactions Associated with Anti-Tuberculosis Therapy",doi:"10.5772/intechopen.97246",slug:"adverse-drug-reactions-associated-with-anti-tuberculosis-therapy",body:'
1. Introduction
The unfortunate tragedy of thalidomide, in 1962, triggered the emergence and implementation of pharmacovigilance across the globe [1]. Thalidomide was introduced in Germany in 1957 and was widely prescribed for the treatment of morning sickness and nausea in pregnant women. Later it was found that babies were born with shortened or absence of limbs (medically known as phocomelia). In 1962, thalidomide was discontinued from the market due to the increased number of scientific reports describing numerous cases of phocomelia [2]. This tragedy led to the creation of the World Health Organization (WHO) pilot research project for International Drug Monitoring in 1968, with the purpose to develop a system and tools applicable internationally, for detecting previously unknown or poorly understood adverse drug reactions (ADRs) of medicines [3]. Currently, this network has been expanded to more than 140 developed, low- and middle-income countries. These 140 countries participated in the WHO programme for international drug monitoring as member states, and 31 countries have also joined as associate member states. These countries have established pharmacovigilance system at their capacity, to monitor the medication safety. WHO and its collaborating centres are continuously providing technical support for capacity building and strengthening of these pharmacovigilance systems [4].
As per WHO, Pharmacovigilance is defined as a “science of detection, assessment, understanding and prevention of ADRs or any other drug related problems” [5]. This enables the scope of clinical practice of monitoring & reporting of ADRs, analyses the information and sharing the learnings with healthcare providers for prevention of such ADRs, for better patient’s safety and outcomes. Pharmacovigilance and its concepts are evolving as one of the most important components in contemporary clinical and regulatory practice. In clinical trials, most medicines will only be tested for short-term safety and efficacy on a limited number of carefully selected individuals (excluding pregnant women, children and elderly). In some cases, as few as 500, and rarely more than 5000, subjects receive the investigational new drug prior to its release [6]. It is not possible to identify and record many ADRs in such a shorter duration, protected environment and restricted population in trials. After stage three of clinical trial, the medicine is available to be launch in the market and is legally set free for consumption by the general population. Post market experience has shown that many adverse effects, interactions (i.e. with foods or other medicines), and risk factors may come to light even after several years of introducing the medicine into the market [7]. Moreover, many studies have shown that an ADR may result into a significantly decrease in the quality of life, increased hospitalizations, prolonged hospital stay and mortality [8]. Therefore, monitoring the safety of the medicines throughout its life period is pivotal, as most of the ADRs are usually reported during prolonged use.
The pharmacovigilance practice applies equally to medicines used in public health programs, including medicines used in Anti-Tubercular Therapy (ATT). As the management of tuberculosis (TB) involves longer duration of therapy and also multiple drugs, these arise as predisposing factors for the occurrence of ADRs [9]. Such ADRs pose a challenge in the management of TB. Though it is a prolonged treatment, medication must be continued in order to ensure the compliance, otherwise it will end with treatment failure or developing antimicrobial resistance [10]. Generally, patients discontinue the medication due to the emergence of ADRs resulting from the administration of first-line anti-TB drugs. During the course of TB treatment, there may be a risk of morbidity and mortality, particularly with drug-induced hepatitis. Therefore, there are public health program in various countries that systematically monitor, prevent and manage ADRs encountered during the treatment of TB, in order to achieve maximum treatment outcomes [11].
TB is a chronic infection caused primarily by Mycobacterium tuberculosis. The lung is generally the first affected organ, as the infection is usually due to inhalation of infected droplet nuclei. Approximately 80% of the TB cases are pulmonary TB [12]. Around 30% patients who are infected with Human Immune Deficiency Virus (HIV) will also develop active tuberculosis. Factors, such as HIV, Resistant TB, drug–drug interactions raise the complexity of problem. As per the WHO strategy, directly observed treatment short-course (DOTS) therapy for the duration of 6–8 months is one of the important components for the treatment of TB. The short-course therapy is usually performed in 2 phases: the initial phase (2 months) involves the concurrent use of at least 3 drugs to rapidly reduce the bacterial population and prevent emergence of drug-resistant bacteria. The second, continuation phase, (4–6 months) involves fewer drugs and is used to eliminate any remaining bacteria and prevent recurrence. Worldwide, HIV infection has been identified as an important predisposing factor of immune-suppression leading to TB [13]. It increases the susceptibility to primary infection and increases the reactivation rate of TB [14]. Although this regimen is effective in treating active TB, it is associated with many ADRs and poses a significant challenge to completion of treatment. Recommended treatment regimens for TB are given in Table 1.
First line drugs given for Drug Sensitive TB
New patients with pulmonary TB should receive a regimen containing 6 months of rifampicin: (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol) *In populations with known or suspected high levels of isoniazid resistance, new TB patients may receive HRE as therapy in the continuation phase. Recommended: 1. Daily dosage 2. Fixed Dose Combination drugs
Second line drugs given for Rifampicin Resistance/Multi Drug Resistance/Extremely Druf Resistance (RR/MDR/XDR) TB and Multi Drug Resistance (MDR-TB)
Group A: Fluoroquinolones Levofloxacin, Moxifloxacin, Gatifloxacin
Group B: Second-line injectable agents Amikacin, Capreomycin, Kanamycin, (Streptomycin)
Group C: Other core second-line agents Ethionamide/prothionamide, Cycloserine/terizidone, Linezolid, Clofazimine
Group D: Add-on agents (not part of the core MDR-TB regimen), D1 Pyrazinamide Ethambutol,High-dose isoniazid
Multiple types of drug therapy are given for TB, and even new TB patients (sensitive to first-line drugs), are receiving a treatment regimen with a combination of four drugs [15]. There is a chance for developing ADR either for one or the combination of drugs, and that has to be identified for ensuring a sustained treatment compliance, till the completion of ATT. When treatment is given to patients with TB-associated drug resistance, either ionized resistance, multidrug resistance or rifampicin resistance, pre-extensively drug resistance or extensively drug resistance TB, the number of drugs given could be higher, and it becomes imperative to identify the resulting/associated ADRs. In case any ADR takes place, the treatment management has to be done appropriately [16]. For TB patients having HIV co-infection, the treatment given for HIV infection, including the antiretroviral therapy, and/or the medication given for the associated conditions, may overlap with the ADR presented, and so it becomes very important to monitor this group of population for efficient management. In addition, also in TB patients with special medical conditions associated, like associated diabetes mellitus, liver, renal or seizure disorders, and psychosis, the treatment should be done cautiously, by closely observing the progress and monitoring all the ADRs encountered. Furthermore, when new drugs like Bedaquiline (BDQ), Delamanid (DLM) and Pretomanid are initiated at TB programs, it is essential that the associated ADRs are captured promptly for effective management of TB [17].
2.1 ADRs associated with first-line anti-TB drugs
The ATT is expected to cause more ADRs, because it involves combination of several medicines and is used for a longer duration [9]. One of the most common ADRs observed with the administration of ATT is gastrointestinal symptoms, such as nausea, vomiting etc. These ADRs could be symptomatically managed without the need for a change in the dosage of drugs. The hepatotoxicity is also a risk associated with ATT, and its frequency can range from 2–39% in different countries [18]. As compared to Western population, Indian sub-population studies reported high incidence of hepatotoxicity with ATT [19].
2.1.1 Isoniazid
Isoniazid has been shown to be well tolerated at recommended dose. However, systemic or cutaneous hypersensitivity reactions can occasionally occur during the first weeks of treatment [15]. By daily supplementary dose of pyridoxine in vulnerable patients, the risk of peripheral neuropathy can be excluded. In the later stages of treatement, some susceptible patients can develop neurological disturbance, encompassing optic neuritis, toxic psychosis and generalized convulsions. This may require the discontinuation of isoniazid. An uncommon but potentially serious reaction is symptomatic hepatitis, which could be precluded by prompt withdrawal of treatment. Asymptomatic rise in serum concentrations of hepatic transaminases at the beginning of treatment has very low clinical significance. The same resolves spontaneously as the treatment carry on. Other rare adverse effects linked with isoniazid are lupus-like syndrome, pellagra, anemia, and arthralgias [20].
2.1.2 Rifampicin
At currently recommended doses, this drug has been shown to be well tolerated by most of the patients. Occasionally it may cause gastrointestinal reactions including abdominal pain, nausea, vomiting and pruritus with or without rash [21]. With an intermittent drug administration, adverse effects, such as fever, influenza-like syndrome and thrombocytopenia may occur. In HIV-positive TB patients, exfoliative dermatitis is more common. Patients taking the drug 3 times a week, adverse effects including temporary oliguria, dyspnoea and haemolytic anemia have been reported. If the regimen is changed to daily dosage these reactions usually subsided. In the beginning of treatment, moderate rises in serum concentrations of bilirubin and transaminases are common adverse effects are often transient and not clinical significant. A potentially fatal condition is dose-related hepatitis, it is therefore important to not exceed the maximum recommended daily dose of 600 mg.
2.1.3 Pyrazinamide
This drug has been reported to cause various skin reactions, like maculopapular rash, erythema multiforme, exfoliative dermatitis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Among the first-line drugs, pyrazinamide has shown to be the most common drug to cause cutaneous ADRs [22]. Pyrazinamide may cause gastrointestinal intolerance. Hypersensitivity reactions are rare, but have been reported in some patients with modest flushed skin. During the early phases of the treatment, moderate rises in serum transaminase concentrations are common. A rare complication is severe hepatotoxicity. A degree of hyperuricaemia may also occur asymptomatically as a result of inhibition of renal tubular secretion [15]. The treatment may also result into gout, which can be treated with allopurinol. Arthralgia, especially of the shoulders, may occur which can be treated with simple analgesics (especially aspirin). By prescribing regimens with intermittent administration of pyrazinamide, hyperuricaemia and arthralgia may be eliminated. Sideroblastic anemia and photosensitive dermatitis are some of the rare ADRs associated with this drug [7, 8].
2.1.4 Streptomycin
Streptomycin injections are painful, and rash, induration, or sterile abscesses can be formed at injection sites. Numbness and tingling around the mouth occur immediately after injection and cutaneous hypersensitivity reactions can occur. The incidence of ototoxicity associated with the use of ATT may be as high as 25% [23]. With currently recommended doses, the complications like impairment of vestibular function are uncommon. Vertigo is more common than hearing loss. Indications of injury at the 8th cranial (auditory) nerve include ringing in the ears, ataxia, vertigo and deafness. The damage is impermanent and can be reversed by reducing in dosage, or the stopping the treatment with this drug. This damage is commonly occurs within the first 2 months of treatment. More commonly, the other aminoglycoside antibiotics e.g. kanamycin, amikacin and capreomycin are more nephrotoxic than streptomycin. If urinary output falls, albuminuria occurs, or tubular casts are detected in the urine, streptomycin should be stopped, and renal function should be evaluated.
Though WHO’s recommendation is not to use injectable streptomycin, we should take into consideration that other recommended treatments with aminoglycosides may cause similar types of ADRs [17].
2.1.5 Ethambutol
Dose-dependent optic neuritis caused by Ethambutol can result in impairment of visual acuity and color vision in one or both eyes. Early changes are usually reversible, but blindness can occur if treatment is not discontinued promptly. Ocular toxicity is rare when ethambutol is used for 2–3 months at recommended doses. Peripheral neuropathy has been reported in approximately 20% of patients treated with ethambutol. Other rare adverse events include generalized cutaneous reaction, arthralgia and, very rarely, hepatitis [24].
Several studies have reported that the drugs used to treat TB may cause ADRs. Management and prevention of such ADRs are important measures to be adopted to increase tolerance. Generally, with non-serious ADRs, the drugs do not need to be stopped, while with serious ADRs, the drugs often have to be stopped and a modified regimen has to be implemented [9].
2.1.6 Capreomycin
This drug is administered in combination with other first-line drugs. The common ADRs reported are hypersensitivity reactions, including urticaria and rashes, nephrotoxicity, electrolyte disturbance, hearing loss wit tinnitus and vertigo [11].
Grading of toxicity associated with drugs used for TB treatment and the ADRs associated with the anti-TB drugs used for therapy are given in Tables 2 and 3, respectively.
Grade & Level
Toxicity
1 - Mild
Transient or mild discomfort; no limitation in activity; no medical intervention or therapy required.
2 – Moderate
Mild to moderate limitation in activity, some assistance may be needed; none or minimal medical intervention or therapy required.
3 - Severe
Marked limitation in activity, some assistance usually required; medical intervention or therapy required, hospitalization is possible.
4 – Life threatening
Extreme limitation in activity, significant assistance required; significant medical intervention or therapy required, hospitalization or hospice care are probable.
Table 2.
Grades of toxicity resulting from TB treatment [25].
Adverse Drug Reaction
Symptoms and signs
Responsible Drug
Audiovestibular manifestations
Hearing loss, vertigo, new-onset tinnitus
Aminoglycosides, Capreomycin
Blood sugar abnormalities
Dizziness, sweating, fainting, poor response to infections
Most common ADRs associated with the use of anti-TB drugs.
2.2 ADRs associated with second-line anti-TB drugs
Resistant -TB is usually treated with a combination of drugs that are more toxic than isoniazid and rifampicin. These drugs include fluoroquinolones, aminoglycosides, ethionamide, cycloserine, aminosalicyclic acid, linezolid and clofazimine, among others [26]. The main ADRs associated with the use of cycloserine are reported as neurological disorders, including headache, dizziness, vertigo, drowsiness, tremor, convulsions, confusion, psychosis, depression, rashes, allergic dermatitis, megaloblastic anemia, and changes in liver function tests [27]. Minor adverse effects are relatively common, and they can be easily managed with symptomatic treatment. However, some adverse effects can be life-threatening, for example, nephrotoxicity due to aminoglycosides, cardiotoxicity due to fluoroquinolones, gastrointestinal toxicity due to ethionamide or para-amino-salicylic acid, central nervous system toxicity due to cycloserine, etc. [17].
2.3 Multi Drug-resistant TB (MDR-TB)
MDR-TB is caused by organisms that are resistant to isoniazid and rifampicin. As per the WHO reports, an estimated 480 000 worldwide patients developed MDR-TB in 2015, in addition to the 100 000 patients with rifampicin-resistant TB that were newly eligible for MDT-TB treatment [22]. Again, according to WHO, the second highest MDR-TB incident country in the world, China, accounted for 45% of the 580 000 cases, together with Indian and the Russian Federations, with 6.6% of new TB cases and 30% of previously treated cases having MDR/Rifampicin resistant TB.
The novel anti tubercular drugs, namely BDQ and DLM, now included in WHO second-line treatment [28], as well as in some countries, have received conditional approval for use in adults with MDR-TB. BDQ, a new anti TB- drug, has been given approval by the United States Food and Drug Administration in 2012 [29], and by the European Medicines Agency in 2014. In India, BDQ was introduced under the conditional access program in 2015. The safety profile and tolerability of a BDQ-containing treatment regimen used in India has been established. QT prolongation in electrocardiogram reading has been reported as one of the most common ADRs with the use of BDQ; the others include peripheral neuropathy, vomiting, breathlessness and thrombocytopenia [30].
2.4 Prevalence of adverse events associated with second-line anti-TB drugs in children
Children, especially those under 10 years old, can tolerate second-line combination of anti-TB drugs better than adults. In children, the higher rate of ADRs has been observed in those having HIV as comorbid infection, as compared to TB infection alone [14]. Several studies have also revealed that the majority of the adverse events found in children are mild to moderate, thus not requiring interruption or complete cessation of treatment. Moreover, even with the occurrence of few severe adverse events, permanent discontinuation of drugs is rarely necessary [14].
The second–line drugs are generally found to cause more ADRs, as compared to the first-line drugs [31]. The healthcare workers treating children should be aware of this fact and should thus be able to manage such ADRs. Healthcare workers, care givers or parents are required to be trained accordingly, because most of the children may not be able to report the drug-associated ADRs. The MDR-TB treatment outcomes in children are well achieved in many countries by using the currently available drugs [32, 33]. However, the improvement of the MDR-TB treatment programme can be achieved by: (1) implementing targeted or cohort event monitoring of adverse events, with the use of MDR-TB drugs in children; and (2) healthcare works training for a timely ADRs reporting, aiming to achieve the maximum treatment outcomes.
2.5 Causality and severity assessment of anti-TB drugs-associated adverse events
After determining the adverse events (suspected) of anti-TB drugs, the very next step is to establish the causal or temporal relationship between the drug and the event, i.e., is the drug actually causing the event? It is possible that the administered drug and the occurrence of an adverse event may have a close temporal relationship, but still not be a reaction [34].
Having considered the parameters in assessing the temporal relationship, the next step is to address the following question: “Did these medicines actually cause the event?” In other words, “Is the event a reaction?” It is conceivable/acceptable that the administration of a medicine and the occurrence of an event may have a close relationship, but still not be a reaction, for example, death from myocardial infarction. In actual practice, the assessment of the relationship and causality frequently merge, particularly when an event is a well-known reaction and the relationship is close. The two phases occur without conscious deliberation, but should be there nevertheless. However, it is often necessary to gather other knowledge about the medicine, the patient and the event, in order to undertake a deliberate evaluation of these factors, which are actually external to the drug–event association that has occurred. Causality assessment is the methodological approach for evaluating a signal (identification of new safety alert) [35]. As per WHO, the causality assessment scale is the estimated strength of the relationship between the drug and the ADR can be classified as certain, probable, possible, unlikely, conditional/unclassified, unassessable/unclassifiable (Table 4). The Naranjo scale can also be applied for causality assessment, and is algorithm-based (Table 5) [38].
Certain
Event of laboratory test abnormality, with plausible time relationship to drug intake
Cannot be explained by disease or other drugs
Response to withdrawal plausible (pharmacologically, pathologically)
Event definitive pharmacologically or phenomenological (An objective and specific medical disorders or a recognized pharmacological phenomenon)
Rechallenge (if necessary)
Probable
Event or lab test abnormality, with reasonable time relationship during intake
Unlikely to be attributed to disease or other drugs
Response to withdrawal clinically reasonable
Rechallenge not necessary
Possible
Event or laboratory test abnormality, with reasonable time relationship to drug intake
Could also be explained by disease or other drugs
Information on drug withdrawal lacking or unclear
Unlikely
Event or laboratory test abnormality with a time to drug that makes a relationship improbable (but not impossible)
Diseases or other drugs provide plausible explanations
Conditional/unclassified
Event or laboratory test abnormality
More data for proper assessment needed
Or additional data under examination
Unassessable/Unclassifiable
A report suggesting an adverse reaction
Cannot be judged because of insufficient or contradictory information
The total score calculated from this table defines the category as:
a. Definite (>9).
b. Probable (5 to 8).
c. Possible (1 to 4).
d. Unlikely (< 0).
The severity assessment of ADRs can also be categorized in to into seven levels of severity level 1 and 2 are considered less severe or mild, levels 3 and 4 are moderate, and levels 5, 6 and 7 are classified as severe [39]. Severe level of ADRs includes all potentially life threatening ADRs, and the ones causing permanent damage or requiring intensive medical care. Even some other assessment scales classify severe and lethal.
3. Conclusions
The emergence of ADRs continues to remain an important public health issue worldwide, as it is among the ten leading causes of mortality. Early identification and prevention of ADRs during TB treatment will lead to the rational use of medicines and to a reduce burden of antimicrobial resistance. Better adherence within the target population will reassure that monitoring and good communication on risks and benefits provide favorable implications for decisions on medicine procurement. Safety monitoring of medicines is thus a vital and crucial element of any health system. As TB treatment relies on a multi-drug therapy for long duration, the emergence of ADRs is inevitable. Therefore, ADR reporting is essential as it will strengthen the evidence, maximize the benefits and minimize the risks.
Abbreviations
ADRs
Adverse Drug Reactions
ATT
Anti-Tubercular Therapy
BDQ
Bedaquiline
DLM
Delamanid
DOTS
Directly Observed Treatment Short-Course
HIV
Human Immunodeficiency Viruses
MDR-TB
Multid Drug-Resistant Tuberculosis
TB
Tuberculosis
WHO
World Health Organization
DRESS
Drug Rash with Eosinophilia and Systemic Symptoms syndrome
\n',keywords:"Adverse Drug Reactions, Anti-Tuberculosis Therapy, Bedaquiline, Pharmacovigilance",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/77033.pdf",chapterXML:"https://mts.intechopen.com/source/xml/77033.xml",downloadPdfUrl:"/chapter/pdf-download/77033",previewPdfUrl:"/chapter/pdf-preview/77033",totalDownloads:302,totalViews:0,totalCrossrefCites:0,dateSubmitted:"June 22nd 2020",dateReviewed:"March 15th 2021",datePrePublished:"June 3rd 2021",datePublished:"October 13th 2021",dateFinished:"June 3rd 2021",readingETA:"0",abstract:"The pharmacovigilance has been evolved as a professional and ethical practice in ensuring the safety of medicines. The Adverse Drug Reactions (ADRs) associated with the use of medicines including Anti-Tuberculous Therapy (ATT) through a robust system of pharmacovigilance helps in promoting the safety of patients at large. The occurrence of ADRs associated with the use of ATT is expected, a large number of medicines are combined and used for prolonged duration. The suspected ADRs associated with first line ATT are well documented. However, the drugs used in second line or multidrug resistant to tuberculosis (TB), namely bedaquiline, reported to cause QT prolongation in electrocardiogram reading as one of the most common ADRs. Therefore, early identification and prevention of ADRs during ATT is essential for promoting the rational use and reduce the burden of anti-microbial resistance, besides achieving better treatment outcomes.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/77033",risUrl:"/chapter/ris/77033",signatures:"Vivekanandan Kalaiselvan, Shatrunajay Shukla, Santhanakrishnan Ramesh Kumar, Nikita Mishra, Pawan Kumar and Rajeev Singh Raghuvanshi",book:{id:"9833",type:"book",title:"New Insights into the Future of Pharmacoepidemiology and Drug Safety",subtitle:null,fullTitle:"New Insights into the Future of Pharmacoepidemiology and Drug Safety",slug:"new-insights-into-the-future-of-pharmacoepidemiology-and-drug-safety",publishedDate:"October 13th 2021",bookSignature:"Maria Teresa Herdeiro, Fátima Roque, Adolfo Figueiras and Tânia Magalhães Silva",coverURL:"https://cdn.intechopen.com/books/images_new/9833.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83968-597-2",printIsbn:"978-1-83968-596-5",pdfIsbn:"978-1-83968-598-9",isAvailableForWebshopOrdering:!0,editors:[{id:"227508",title:"Prof.",name:"Maria Teresa",middleName:null,surname:"Herdeiro",slug:"maria-teresa-herdeiro",fullName:"Maria Teresa Herdeiro"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"253107",title:"Dr.",name:"Vivekanandan",middleName:null,surname:"Kalaiselvan",fullName:"Vivekanandan Kalaiselvan",slug:"vivekanandan-kalaiselvan",email:"vivekarts@gmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"419637",title:"Dr.",name:"Shatrunajay",middleName:null,surname:"Shukla",fullName:"Shatrunajay Shukla",slug:"shatrunajay-shukla",email:"dummy+419637@intechopen.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"419638",title:"Dr.",name:"S.",middleName:null,surname:"Ramesh Kumar",fullName:"S. Ramesh Kumar",slug:"s.-ramesh-kumar",email:"dummy+419638@intechopen.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"419639",title:"Dr.",name:"Nikita",middleName:null,surname:"Mishra",fullName:"Nikita Mishra",slug:"nikita-mishra",email:"dummy+419639@intechopen.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"419640",title:"Dr.",name:"Pawan",middleName:null,surname:"Kumar",fullName:"Pawan Kumar",slug:"pawan-kumar",email:"dummy+419640@intechopen.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"419641",title:"Dr.",name:"Rajeev Singh",middleName:null,surname:"Raghuvanshi",fullName:"Rajeev Singh Raghuvanshi",slug:"rajeev-singh-raghuvanshi",email:"dummy+419641@intechopen.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Importance of ADR reporting in tuberculosis",level:"1"},{id:"sec_2_2",title:"2.1 ADRs associated with first-line anti-TB drugs",level:"2"},{id:"sec_2_3",title:"2.1.1 Isoniazid",level:"3"},{id:"sec_3_3",title:"2.1.2 Rifampicin",level:"3"},{id:"sec_4_3",title:"2.1.3 Pyrazinamide",level:"3"},{id:"sec_5_3",title:"2.1.4 Streptomycin",level:"3"},{id:"sec_6_3",title:"2.1.5 Ethambutol",level:"3"},{id:"sec_7_3",title:"Table 2.",level:"3"},{id:"sec_9_2",title:"2.2 ADRs associated with second-line anti-TB drugs",level:"2"},{id:"sec_10_2",title:"2.3 Multi Drug-resistant TB (MDR-TB)",level:"2"},{id:"sec_11_2",title:"2.4 Prevalence of adverse events associated with second-line anti-TB drugs in children",level:"2"},{id:"sec_12_2",title:"2.5 Causality and severity assessment of anti-TB drugs-associated adverse events",level:"2"},{id:"sec_14",title:"3. Conclusions",level:"1"},{id:"sec_17",title:"Abbreviations",level:"1"}],chapterReferences:[{id:"B1",body:'N. Vargesson, “Thalidomide Embryopathy: An Enigmatic Challenge,” ISRN Developmental Biology, Oct. 31, 2013. https://www.hindawi.com/journals/isrn/2013/241016/ (accessed Feb. 24, 2021).'},{id:"B2",body:'N. Vargesson, “Thalidomide-induced teratogenesis: history and mechanisms,” Birth Defects Res C Embryo Today, vol. 105, no. 2, pp. 140-156, Jun. 2015, doi: 10.1002/bdrc.21096.'},{id:"B3",body:'W. H. Organization, Handbook of resolutions and decisions of the World Health Assembly and the Executive Board. World Health Organization, 1973.'},{id:"B4",body:'D. N. Iessa, “Pharmacovigilance: New Challenges for WHO,” p. 52.'},{id:"B5",body:'“Pharmacovigilance - an overview | ScienceDirect Topics.” https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/pharmacovigilance (accessed Feb. 24, 2021).'},{id:"B6",body:'J. A. Berlin, S. C. Glasser, and S. S. Ellenberg, “Adverse Event Detection in Drug Development: Recommendations and Obligations Beyond Phase 3,” Am J Public Health, vol. 98, no. 8, pp. 1366-1371, Aug. 2008, doi: 10.2105/AJPH.2007.124537.'},{id:"B7",body:'N. Raj, S. Fernandes, N. R. Charyulu, A. Dubey, R. G. S., and S. Hebbar, “Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada,” Ther Adv Drug Saf, vol. 10, Jul. 2019, doi: 10.1177/2042098619865413.'},{id:"B8",body:'R. I. Thomas, D. J. Cameron, and M. C. Fahs, “A Prospective Study of Delirium and Prolonged Hospital Stay: Exploratory Study,” Archives of General Psychiatry, vol. 45, no. 10, pp. 937-940, Oct. 1988, doi: 10.1001/archpsyc.1988.01800340065009.'},{id:"B9",body:'“A practical handbook on the pharmacovigilance of medicines used in the treatment of tuberculosis.” Accessed: Mar. 17, 2021. [Online]. Available: https://www.who.int/docs/default-source/documents/tuberculosis/a-practical-handbook-on-the-pharmacovigilance-of-medicines-used-in-the-treatment-of-tuberculosis.pdf?sfvrsn=6e5fc0cf_5.'},{id:"B10",body:'F. Imam et al., “Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs,” Saudi Pharmaceutical Journal, vol. 28, no. 3, pp. 316-324, Mar. 2020, doi: 10.1016/j.jsps.2020.01.011.'},{id:"B11",body:'“Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India Agrawal V, Shrivastava TP, Adusumilli PK, Vivekanandan K, Thota P, Bhushan S - Perspect Clin Res.” https://www.picronline.org/article.asp?issn=2229-3485;year=2019;volume=10;issue=3;spage=140;epage=144;aulast=Agrawal (accessed Mar. 17, 2021).'},{id:"B12",body:'C. Hoffmann, “Pulmonary tuberculosis in adults,” in Tuberculosis, Elsevier, 2009, pp. 332-341.'},{id:"B13",body:'T. T. Todorova, G. Tsankova, and N. L. and T. Kostadinova, “Tuberculosis and HIV — Doubling the Fatality,” Immunopathology and Immunomodulation, Nov. 2015, doi: 10.5772/61138.'},{id:"B14",body:'J. Bruchfeld, M. Correia-Neves, and G. Källenius, “Tuberculosis and HIV Coinfection,” Cold Spring Harb Perspect Med, vol. 5, no. 7, Jul. 2015, doi: 10.1101/cshperspect.a017871.'},{id:"B15",body:'World Health Organization and Stop TB Initiative (World Health Organization), Eds., Treatment of tuberculosis: guidelines, 4th ed. Geneva: World Health Organization, 2010.'},{id:"B16",body:'“WHO_HTM_TB_2014.23_eng.pdf.” Accessed: Mar. 17, 2021. [Online]. Available: https://apps.who.int/iris/bitstream/handle/10665/137334/WHO_HTM_TB_2014.23_eng.pdf;jsessionid=3F28C9E7FB3CC604788D92E5CEB971F8?sequence=1.'},{id:"B17",body:'World Health Organization, WHO consolidated guidelines on drug-resistant tuberculosis treatment. 2019.'},{id:"B18",body:'“Risk Factors of Hepatotoxicity During Anti-tuberculosis Treatment.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923276/ (accessed Feb. 24, 2021).'},{id:"B19",body:'P. R et al., “Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide,” Tubercle, Jun. 1986. https://pubmed.ncbi.nlm.nih.gov/3775870/ (accessed Feb. 24, 2021).'},{id:"B20",body:'“WHO | Toman’s tuberculosis: case detection, treatment and monitoring: questions and answers (2nd edition),” WHO. https://www.who.int/tb/publications/toman/en/ (accessed Feb. 24, 2021).'},{id:"B21",body:'“Treatment of Tuberculosis American Thoracic Society, CDC, and Infectious Diseases Society of America.” https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm (accessed Feb. 24, 2021).'},{id:"B22",body:'“Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis - Clinical Epidemiology and Global Health.” https://cegh.net/article/S2213-3984(15)00073−1/fulltext (accessed Feb. 24, 2021).'},{id:"B23",body:'M. Rd, S. Cr, and L. Ps, “Risk factors for the development of auditory toxicity in patients receiving aminoglycosides,” The Journal of infectious diseases, Jan. 1984. https://pubmed.ncbi.nlm.nih.gov/6693788/ (accessed Feb. 24, 2021).'},{id:"B24",body:'X. Lv et al., “Adverse Reactions Due to Directly Observed Treatment Strategy Therapy in Chinese Tuberculosis Patients: A Prospective Study,” PLOS ONE, vol. 8, no. 6, p. e65037, Jun. 2013, doi: 10.1371/journal.pone.0065037.'},{id:"B25",body:'C. Sekaggya-Wiltshire et al., “Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients,” J Antimicrob Chemother, vol. 72, no. 4, pp. 1172-1177, Apr. 2017, doi: 10.1093/jac/dkw534.'},{id:"B26",body:'K. E. Dooley et al., “Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis,” Clinical Infectious Diseases, vol. 55, no. 4, pp. 572-581, Aug. 2012, doi: 10.1093/cid/cis487.'},{id:"B27",body:'“National Formulary of India 5th Edition, 2016, Page 208.” Indian Pharmacopoeia Commission.'},{id:"B28",body:'M. Grzemska, “Updated WHO MDR-TB treatment guidelines and the use of new drugs in children,” Resid Pediatr, vol. 7, no. Supl, pp. 7-10, Oct. 2017, doi: 10.25060/residpediatr-2017.v7s1-03.'},{id:"B29",body:'S. Yadav, G. Rawal, and M. Baxi, “Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis,” J Clin Diagn Res, vol. 10, no. 8, pp. FM01–FM02, Aug. 2016, doi: 10.7860/JCDR/2016/19052.8286.'},{id:"B30",body:'“Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis - PubMed.” https://pubmed.ncbi.nlm.nih.gov/32192613/ (accessed Feb. 24, 2021).'},{id:"B31",body:'“First– and Second–Line Drugs and Drug Resistance | IntechOpen.” https://www.intechopen.com/books/tuberculosis-current-issues-in-diagnosis-and-management/first-and-second-line-drugs-and-drug-resistance (accessed Feb. 24, 2021).'},{id:"B32",body:'H. H. Tola, K. J. Khadoura, W. Jimma, S. Nedjat, and R. Majdzadeh, “Multidrug resistant tuberculosis treatment outcome in children in developing and developed countries: A systematic review and meta-analysis,” International Journal of Infectious Diseases, vol. 96, pp. 12-18, Jul. 2020, doi: 10.1016/j.ijid.2020.03.064.'},{id:"B33",body:'H. S. Schaaf, S. Thee, L. van der Laan, A. C. Hesseling, and A. J. Garcia-Prats, “Adverse effects of oral second-line antituberculosis drugs in children,” Expert Opin Drug Saf, vol. 15, no. 10, pp. 1369-1381, Oct. 2016, doi: 10.1080/14740338.2016.1216544.'},{id:"B34",body:'H. S. Rehan, D. Chopra, and A. K. Kakkar, “Physician’s guide to pharmacovigilance: Terminology and causality assessment,” European Journal of Internal Medicine, vol. 20, no. 1, pp. 3-8, Jan. 2009, doi: 10.1016/j.ejim.2008.04.019.'},{id:"B35",body:'“UMC | What is a signal?” https://www.who-umc.org/research-scientific-development/signal-detection/what-is-a-signal/ (accessed Mar. 17, 2021).'},{id:"B36",body:'S. A. Zaki, “Adverse drug reaction and causality assessment scales,” Lung India, vol. 28, no. 2, pp. 152-153, 2011, doi: 10.4103/0970-2113.80343.'},{id:"B37",body:'“ADVERSE DRUG REACTION-CAUSALITY ASSESSMENT.” Accessed: Mar. 17, 2021. [Online]. Available: http://www.ijrpc.com/files/00050.pdf.'},{id:"B38",body:'R. P. Naidu, “Causality assessment: A brief insight into practices in pharmaceutical industry,” Perspect Clin Res, vol. 4, no. 4, pp. 233-236, 2013, doi: 10.4103/2229-3485.120173.'},{id:"B39",body:'S. C. Hartwig, J. Siegel, and P. J. Schneider, “Preventability and severity assessment in reporting adverse drug reactions,” Am J Hosp Pharm, vol. 49, no. 9, pp. 2229-2232, Sep. 1992.'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Vivekanandan Kalaiselvan",address:"vivekarts@gmail.com;, kalaiselvan.ipc@gov.in",affiliation:'
Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, India
Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, India
'}],corrections:null},book:{id:"9833",type:"book",title:"New Insights into the Future of Pharmacoepidemiology and Drug Safety",subtitle:null,fullTitle:"New Insights into the Future of Pharmacoepidemiology and Drug Safety",slug:"new-insights-into-the-future-of-pharmacoepidemiology-and-drug-safety",publishedDate:"October 13th 2021",bookSignature:"Maria Teresa Herdeiro, Fátima Roque, Adolfo Figueiras and Tânia Magalhães Silva",coverURL:"https://cdn.intechopen.com/books/images_new/9833.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83968-597-2",printIsbn:"978-1-83968-596-5",pdfIsbn:"978-1-83968-598-9",isAvailableForWebshopOrdering:!0,editors:[{id:"227508",title:"Prof.",name:"Maria Teresa",middleName:null,surname:"Herdeiro",slug:"maria-teresa-herdeiro",fullName:"Maria Teresa Herdeiro"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"208595",title:"Dr.",name:"Enrique",middleName:null,surname:"Rojas-Campos",email:"erojascampos@yahoo.com.mx",fullName:"Enrique Rojas-Campos",slug:"enrique-rojas-campos",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:null},booksEdited:[],chaptersAuthored:[{id:"59088",title:"Vascular Calcification and Oxidative DNA Damage as Nontraditional Cardiovascular Risk Factors in Chronic Renal Disease",slug:"vascular-calcification-and-oxidative-dna-damage-as-nontraditional-cardiovascular-risk-factors-in-chr",abstract:"The number of CKD sufferers that require renal replacement techniques (RRTs) is increasing. The severity of cardiovascular disease (CVD) is disproportionate in these kinds of patients and contributes considerably to mortality in CKD patients. We evaluated the association between oxidative DNA damage, antioxidant activity and vascular calcification (VC) in CKD. An analytical cross-sectional study was performed. Two simple plaques were taken for each patient (pelvis-hip, and hands-wrists). The presence of VC was scored as presence (1) and absence (0). Oxidative stress was determined by activity of catalase, superoxide dismutase (SOD) and oxidative DNA damage by determination of 8-OHdG marker. Eighty-one patients were included. The RRT type was similar for hemodialysis (HD) and peritoneal dialysis (PD). Thirty-eight patients (47%) presented VC (p < 0.01); in 61%, the VC was severe (≥3 points). VC prevalence in women was significantly higher, (67%) (p < 0.001), and (29%) men. Sixty four percent of the patients submitted to HD presented VC and 27% to PD (p < 0.001). The activity of the catalase enzyme was significantly decreased in CKD vs. the healthy control (HC) (p < 0.0001). The oxidative DNA damage in CKD was greater vs. HC (p < 0.0001). In conclusion, the VC was frequent (47%) in CKD, and decreased catalase activity and greater oxidative DNA damage.",signatures:"Edith Viridiana Alatorre-Moreno, José Ignacio Cerrillos-Gutiérrez,\nJorge Andrade-Sierra, Enrique Rojas-Campos, Sandra Carrillo-Ibarra,\nSonia Sifuentes-Franco, Andrés García-Sánchez and Alejandra\nGuillermina Miranda-Díaz",authors:[{id:"178033",title:"Dr.",name:"Alejandra Guillermina",surname:"Miranda-Diaz",fullName:"Alejandra Guillermina Miranda-Diaz",slug:"alejandra-guillermina-miranda-diaz",email:"kindalex1@outlook.com"},{id:"202798",title:"Dr.",name:"Jorge",surname:"Andrade-Sierra",fullName:"Jorge Andrade-Sierra",slug:"jorge-andrade-sierra",email:"jorg_andrade@hotmail.com"},{id:"208589",title:"Dr.",name:"Sonia",surname:"Sifuentes-Franco",fullName:"Sonia Sifuentes-Franco",slug:"sonia-sifuentes-franco",email:"sifuentes_sf05@hotmail.com"},{id:"208590",title:"Dr.",name:"Sandra",surname:"Carrillo-Ibarra",fullName:"Sandra Carrillo-Ibarra",slug:"sandra-carrillo-ibarra",email:"sann_dy31@hotmail.com"},{id:"208591",title:"Dr.",name:"José Ignacio",surname:"Cerrillos-Gutiérrez",fullName:"José Ignacio Cerrillos-Gutiérrez",slug:"jose-ignacio-cerrillos-gutierrez",email:"chachisnefro@hotmail.com"},{id:"208595",title:"Dr.",name:"Enrique",surname:"Rojas-Campos",fullName:"Enrique Rojas-Campos",slug:"enrique-rojas-campos",email:"erojascampos@yahoo.com.mx"},{id:"222295",title:"Dr.",name:"Edith Viridiana",surname:"Alatorre-Moreno",fullName:"Edith Viridiana Alatorre-Moreno",slug:"edith-viridiana-alatorre-moreno",email:"ediviridiana@hotmail.com"},{id:"222296",title:"Mr.",name:"Andrés",surname:"García-Sánchez",fullName:"Andrés García-Sánchez",slug:"andres-garcia-sanchez",email:"andres_garciasanchez_3@hotmail.com"}],book:{id:"6397",title:"Free Radicals, Antioxidants and Diseases",slug:"free-radicals-antioxidants-and-diseases",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"178033",title:"Dr.",name:"Alejandra Guillermina",surname:"Miranda-Diaz",slug:"alejandra-guillermina-miranda-diaz",fullName:"Alejandra Guillermina Miranda-Diaz",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"178299",title:"Dr.",name:"Cleva",surname:"Villanueva",slug:"cleva-villanueva",fullName:"Cleva Villanueva",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Instituto Politécnico Nacional",institutionURL:null,country:{name:"Mexico"}}},{id:"178301",title:"Dr.",name:"Robert",surname:"Kross",slug:"robert-kross",fullName:"Robert Kross",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"178302",title:"Dr.",name:"Luis",surname:"Perez-Astudillo",slug:"luis-perez-astudillo",fullName:"Luis Perez-Astudillo",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"202798",title:"Dr.",name:"Jorge",surname:"Andrade-Sierra",slug:"jorge-andrade-sierra",fullName:"Jorge Andrade-Sierra",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:"Servicio de Nefrología, Hospital Civil de Guadalajara. “Dr. Juan I. Menchaca” Guadalajara, Jalisco. México",institution:null},{id:"208589",title:"Dr.",name:"Sonia",surname:"Sifuentes-Franco",slug:"sonia-sifuentes-franco",fullName:"Sonia Sifuentes-Franco",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"208590",title:"Dr.",name:"Sandra",surname:"Carrillo-Ibarra",slug:"sandra-carrillo-ibarra",fullName:"Sandra Carrillo-Ibarra",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"208591",title:"Dr.",name:"José Ignacio",surname:"Cerrillos-Gutiérrez",slug:"jose-ignacio-cerrillos-gutierrez",fullName:"José Ignacio Cerrillos-Gutiérrez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"222295",title:"Dr.",name:"Edith Viridiana",surname:"Alatorre-Moreno",slug:"edith-viridiana-alatorre-moreno",fullName:"Edith Viridiana Alatorre-Moreno",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"222296",title:"Mr.",name:"Andrés",surname:"García-Sánchez",slug:"andres-garcia-sanchez",fullName:"Andrés García-Sánchez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"attribution-policy",title:"Attribution Policy",intro:"
Definition of Terms:
\n\n
Book - collection of Works distributed in a book format, whose selection, coordination, preparation, and arrangement has been performed and published by IntechOpen, and in which the Work is included in its entirety in an unmodified form along with one or more other contributions, each constituting separate and independent sections, but together assembled into a collective whole.
",metaTitle:"Attribution Policy",metaDescription:"DEFINITION OF TERMS",metaKeywords:null,canonicalURL:"/page/attribution-policy",contentRaw:'[{"type":"htmlEditorComponent","content":"
Work - a book Chapter (as well as Conference Papers), including any and all content, graphics, images and/or other materials forming part of, or accompanying, the Chapter/Conference Paper.
\\n\\n
Attribution – appropriate credit for the used Work or book.
\\n\\n
Creative Commons licenses – enable licensors to retain copyright while allowing others to use their Works in an appropriate way.
\\n\\n
Rules of Attribution for Works Published by IntechOpen
\\n\\n
With the purpose of protecting Authors' copyright and the transparent reuse of OA (Open Access) content, IntechOpen has developed Rules of Attribution of Works licensed under Creative Commons licenses.
\\n\\n
\\n\\t
All Chapters published in IntechOpen books prior to October 2011 are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported license (CC BY-NC-SA 3.0);
\\n\\t
All Chapters published in IntechOpen books after October 2011 are licensed under the Creative Commons Attribution 3.0 Unported license (CC BY 3.0);
\\n
\\n\\n
In case you reuse or republish any of the Works licensed under CC licenses, you must abide by the guidelines outlined below:
\\n\\n
1. Rules for reusing of books in their entirety or significant parts of books
\\n\\n
All rights to Books and other compilations published on the IntechOpen platform and in print are reserved by IntechOpen. The Copyright to Books and other compilations is subject to a separate Copyright from any that exists in the included Works.
\\n\\n
A Book in its entirety or a significant part of a Book cannot be translated freely without specific written consent by the publisher. Further information can be obtained at permissions@intechopen.com.
\\n\\n
In instances where permission is obtained from the publisher for reusing or republishing the Book, or significant parts of the Book, all of the following conditions apply:
\\n\\n
\\n\\t
Information about the first publisher must be provided – please note the fact that the material was originally published by IntechOpen as an OA (Open Access) publication must be acknowledged;
\\n\\t
All original Academic Editor(s) must be credited;
\\n\\t
Since you are reusing content that someone else created and allowed you to use freely, you must credit all Authors involved;
\\n\\t
The type of license that is available for the Works must be indicated, as well as a link to the license provided, so that others can investigate the terms of the license. You will be aware that the material can be used for free in consequence of the CC license attribution, so you must acknowledge that fact. It is not sufficient that the material is Creative Commons, because that says nothing about how the material can actually be used. There are different CC licenses and you have to identify the specific license that is being used;
\\n\\t
Any original Copyright Notices associated, with the Works which constitute the Book must be kept intact;
\\n\\t
Provision of the original title of the Book, as well as the original titles of any individual Works;
\\n\\t
Provision of the URL where the Book is hosted, with a notice to the effect that the Book is an OA (Open Access) publication;
\\n\\t
Provision of the URL to every individual Work which constitutes the Book with a notice that the Work is an OA (Open Access) publication. As the material has been accessed for free, it is incumbent upon you to provide the source so that others can also access it for free.
\\n
\\n\\n
Every single Work that is used has to be attributed in the way described. If you are unsure about proper attribution, please write to permissions@intechopen.com.
\\n\\n
2. Rules of attribution for works published by IntechOpen
\\n\\n
Individual Works originally published in IntechOpen books are licensed under Creative Commons licenses and can be freely used under terms of the respective CC license, if properly attributed. In order to properly attribute the Work you must respect all the conditions outlined below:
\\n\\n
\\n\\t
Credit all Authors – since you are reusing contents that someone created and allowed you to use freely, you have to acknowledge authorship;
\\n\\t
Indicate the type of license under which the Work is available and provide the URL to the license so others can find out the license terms. Preferably keep intact any original Copyright Notice associated with the Chapter (if any). You will be aware that the material can be used for free in consequence of the CC license attribution, so you must acknowledge that fact. It is not sufficient that the material is Creative Commons, because that says nothing about how the material can actually be used. There are different CC licenses and you have to identify the specific license that is being used;
\\n\\t
Provide the URL where the Work is hosted, preferably providing the original title of the Work, as well as the original title of the Book with a notification that the Work is an OA (Open Access) publication. As the material has been accessed for free, it is incumbent upon you to provide the source so that others can also access it for free;
\\n\\t
Provide information about the first publisher – please note the fact that the material was originally published by IntechOpen as an OA (Open Access) Work must be acknowledged.
\\n
\\n\\n
Every single Work that is used has to be attributed in the way as described. If you are unsure about proper attribution, please contact Us at permissions@intechopen.com.
\\n\\n
In the event that you use more than one of IntechOpen's Works published in one or more books (but not a significant part of the book that is under separate Copyright), each of these have to be properly attributed in the way described.
\\n\\n
IntechOpen does not have any claims on newly created copyrighted Works, but the Works originally published by IntechOpen must be properly attributed.
\\n\\n
All these rules apply to BOTH online and offline use.
\\n\\n
Parts of the Rules of Attribution are based on Work Attributing Creative Commons Materials published by the Australian Research Council Centre of Excellence for Creative Industries and Innovation, in partnership with Creative Commons Australia, which can be found at creativecommons.org.au licensed under Creative Commons Attribution 2.5 Australia license, and Best practices for attribution published by Creative Commons, which can be found at wiki.creativecommons.org under the Creative Commons Attribution 4.0 license.
\\n\\n
All the above rules are subject to change, IntechOpen reserves the right to take appropriate action if any of the conditions outlined above are not met.
Work - a book Chapter (as well as Conference Papers), including any and all content, graphics, images and/or other materials forming part of, or accompanying, the Chapter/Conference Paper.
\n\n
Attribution – appropriate credit for the used Work or book.
\n\n
Creative Commons licenses – enable licensors to retain copyright while allowing others to use their Works in an appropriate way.
\n\n
Rules of Attribution for Works Published by IntechOpen
\n\n
With the purpose of protecting Authors' copyright and the transparent reuse of OA (Open Access) content, IntechOpen has developed Rules of Attribution of Works licensed under Creative Commons licenses.
\n\n
\n\t
All Chapters published in IntechOpen books prior to October 2011 are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported license (CC BY-NC-SA 3.0);
\n\t
All Chapters published in IntechOpen books after October 2011 are licensed under the Creative Commons Attribution 3.0 Unported license (CC BY 3.0);
\n
\n\n
In case you reuse or republish any of the Works licensed under CC licenses, you must abide by the guidelines outlined below:
\n\n
1. Rules for reusing of books in their entirety or significant parts of books
\n\n
All rights to Books and other compilations published on the IntechOpen platform and in print are reserved by IntechOpen. The Copyright to Books and other compilations is subject to a separate Copyright from any that exists in the included Works.
\n\n
A Book in its entirety or a significant part of a Book cannot be translated freely without specific written consent by the publisher. Further information can be obtained at permissions@intechopen.com.
\n\n
In instances where permission is obtained from the publisher for reusing or republishing the Book, or significant parts of the Book, all of the following conditions apply:
\n\n
\n\t
Information about the first publisher must be provided – please note the fact that the material was originally published by IntechOpen as an OA (Open Access) publication must be acknowledged;
\n\t
All original Academic Editor(s) must be credited;
\n\t
Since you are reusing content that someone else created and allowed you to use freely, you must credit all Authors involved;
\n\t
The type of license that is available for the Works must be indicated, as well as a link to the license provided, so that others can investigate the terms of the license. You will be aware that the material can be used for free in consequence of the CC license attribution, so you must acknowledge that fact. It is not sufficient that the material is Creative Commons, because that says nothing about how the material can actually be used. There are different CC licenses and you have to identify the specific license that is being used;
\n\t
Any original Copyright Notices associated, with the Works which constitute the Book must be kept intact;
\n\t
Provision of the original title of the Book, as well as the original titles of any individual Works;
\n\t
Provision of the URL where the Book is hosted, with a notice to the effect that the Book is an OA (Open Access) publication;
\n\t
Provision of the URL to every individual Work which constitutes the Book with a notice that the Work is an OA (Open Access) publication. As the material has been accessed for free, it is incumbent upon you to provide the source so that others can also access it for free.
\n
\n\n
Every single Work that is used has to be attributed in the way described. If you are unsure about proper attribution, please write to permissions@intechopen.com.
\n\n
2. Rules of attribution for works published by IntechOpen
\n\n
Individual Works originally published in IntechOpen books are licensed under Creative Commons licenses and can be freely used under terms of the respective CC license, if properly attributed. In order to properly attribute the Work you must respect all the conditions outlined below:
\n\n
\n\t
Credit all Authors – since you are reusing contents that someone created and allowed you to use freely, you have to acknowledge authorship;
\n\t
Indicate the type of license under which the Work is available and provide the URL to the license so others can find out the license terms. Preferably keep intact any original Copyright Notice associated with the Chapter (if any). You will be aware that the material can be used for free in consequence of the CC license attribution, so you must acknowledge that fact. It is not sufficient that the material is Creative Commons, because that says nothing about how the material can actually be used. There are different CC licenses and you have to identify the specific license that is being used;
\n\t
Provide the URL where the Work is hosted, preferably providing the original title of the Work, as well as the original title of the Book with a notification that the Work is an OA (Open Access) publication. As the material has been accessed for free, it is incumbent upon you to provide the source so that others can also access it for free;
\n\t
Provide information about the first publisher – please note the fact that the material was originally published by IntechOpen as an OA (Open Access) Work must be acknowledged.
\n
\n\n
Every single Work that is used has to be attributed in the way as described. If you are unsure about proper attribution, please contact Us at permissions@intechopen.com.
\n\n
In the event that you use more than one of IntechOpen's Works published in one or more books (but not a significant part of the book that is under separate Copyright), each of these have to be properly attributed in the way described.
\n\n
IntechOpen does not have any claims on newly created copyrighted Works, but the Works originally published by IntechOpen must be properly attributed.
\n\n
All these rules apply to BOTH online and offline use.
\n\n
Parts of the Rules of Attribution are based on Work Attributing Creative Commons Materials published by the Australian Research Council Centre of Excellence for Creative Industries and Innovation, in partnership with Creative Commons Australia, which can be found at creativecommons.org.au licensed under Creative Commons Attribution 2.5 Australia license, and Best practices for attribution published by Creative Commons, which can be found at wiki.creativecommons.org under the Creative Commons Attribution 4.0 license.
\n\n
All the above rules are subject to change, IntechOpen reserves the right to take appropriate action if any of the conditions outlined above are not met.
\n\n
Policy last updated: 2016-06-09
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"58592",title:"Dr.",name:"Arun",middleName:null,surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/58592/images/1664_n.jpg",biography:"Arun K. Shanker is serving as a Principal Scientist (Plant Physiology) with the Indian Council of Agricultural Research (ICAR) at the Central Research Institute for Dryland Agriculture in Hyderabad, India. He is working with the ICAR as a full time researcher since 1993 and has since earned his Advanced degree in Crop Physiology while in service. He has been awarded the prestigious Member of the Royal Society of Chemistry (MRSC), by the Royal Society of Chemistry, London in 2015. Presently he is working on systems biology approach to study the mechanism of abiotic stress tolerance in crops. His main focus now is to unravel the mechanism of drought and heat stress response in plants to tackle climate change related threats in agriculture.",institutionString:null,institution:{name:"Indian Council of Agricultural Research",country:{name:"India"}}},{id:"4782",title:"Prof.",name:"Bishnu",middleName:"P",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/4782/images/system/4782.jpg",biography:"Bishnu P. Pal is Professor of Physics at Mahindra École\nCentrale Hyderabad India since July 1st 2014 after retirement\nas Professor of Physics from IIT Delhi; Ph.D.’1975 from IIT\nDelhi; Fellow of OSA and SPIE; Senior Member IEEE;\nHonorary Foreign Member Royal Norwegian Society for\nScience and Arts; Member OSA Board of Directors (2009-\n11); Distinguished Lecturer IEEE Photonics Society (2005-\n07).",institutionString:null,institution:{name:"Indian Institute of Technology Delhi",country:{name:"India"}}},{id:"69653",title:"Dr.",name:"Chusak",middleName:null,surname:"Limsakul",slug:"chusak-limsakul",fullName:"Chusak Limsakul",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Prince of Songkla University",country:{name:"Thailand"}}},{id:"23804",title:"Dr.",name:"Hamzah",middleName:null,surname:"Arof",slug:"hamzah-arof",fullName:"Hamzah Arof",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/23804/images/5492_n.jpg",biography:"Hamzah Arof received his BSc from Michigan State University, and PhD from the University of Wales. Both degrees were in electrical engineering. His current research interests include signal processing and photonics. Currently he is affiliated with the Department of Electrical Engineering, University of Malaya, Malaysia.",institutionString:null,institution:{name:"University of Malaya",country:{name:"Malaysia"}}},{id:"41989",title:"Prof.",name:"He",middleName:null,surname:"Tian",slug:"he-tian",fullName:"He Tian",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"East China University of Science and Technology",country:{name:"China"}}},{id:"33351",title:null,name:"Hendra",middleName:null,surname:"Hermawan",slug:"hendra-hermawan",fullName:"Hendra Hermawan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/33351/images/168_n.jpg",biography:null,institutionString:null,institution:{name:"Institut Teknologi Bandung",country:{name:"Indonesia"}}},{id:"11981",title:"Prof.",name:"Hiroshi",middleName:null,surname:"Ishiguro",slug:"hiroshi-ishiguro",fullName:"Hiroshi Ishiguro",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRglaQAC/Profile_Picture_1626411846553",biography:"Hiroshi Ishiguro is an award-winning roboticist and innovator. As the Director of the Intelligent Robotics Laboratory, which is part of the Department of Systems Innovation in the Graduate School of Engineering Science at Osaka University, Japan, Ishiguro concentrates on making robots that are similar as possible to humans to understand the human species. A notable project of his laboratory is the Actroid, a humanoid robot with a lifelike appearance and observable behavior such as facial movements. (Sources: http://www.geminoid.jp/en/index.html, https://en.wikipedia.org/wiki/Hiroshi_Ishiguro)",institutionString:null,institution:{name:"Osaka University",country:{name:"Japan"}}},{id:"45747",title:"Dr.",name:"Hsin-I",middleName:null,surname:"Chang",slug:"hsin-i-chang",fullName:"Hsin-I Chang",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"National Chiayi University",country:{name:"Taiwan"}}},{id:"61581",title:"Dr.",name:"Joy Rizki Pangestu",middleName:null,surname:"Djuansjah",slug:"joy-rizki-pangestu-djuansjah",fullName:"Joy Rizki Pangestu Djuansjah",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/61581/images/237_n.jpg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"94249",title:"Prof.",name:"Junji",middleName:null,surname:"Kido",slug:"junji-kido",fullName:"Junji Kido",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Yamagata University",country:{name:"Japan"}}},{id:"12009",title:"Dr.",name:"Ki Young",middleName:null,surname:"Kim",slug:"ki-young-kim",fullName:"Ki Young Kim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12009/images/system/12009.jpg",biography:"Http://m80.knu.ac.kr/~doors",institutionString:null,institution:{name:"National Cheng Kung University",country:{name:"Taiwan"}}},{id:"132595",title:"Prof.",name:"Long",middleName:null,surname:"Wang",slug:"long-wang",fullName:"Long Wang",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Peking University",country:{name:"China"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6583},{group:"region",caption:"Middle and South America",value:2,count:5888},{group:"region",caption:"Africa",value:3,count:2381},{group:"region",caption:"Asia",value:4,count:12511},{group:"region",caption:"Australia and Oceania",value:5,count:1006},{group:"region",caption:"Europe",value:6,count:17529}],offset:12,limit:12,total:12514},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"dateEndThirdStepPublish",topicId:"161925"},books:[],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:43},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:11},{group:"topic",caption:"Business, Management and Economics",value:7,count:6},{group:"topic",caption:"Chemistry",value:8,count:21},{group:"topic",caption:"Computer and Information Science",value:9,count:21},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:17},{group:"topic",caption:"Engineering",value:11,count:59},{group:"topic",caption:"Environmental Sciences",value:12,count:8},{group:"topic",caption:"Immunology and Microbiology",value:13,count:10},{group:"topic",caption:"Materials Science",value:14,count:27},{group:"topic",caption:"Mathematics",value:15,count:9},{group:"topic",caption:"Medicine",value:16,count:122},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:9},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:7},{group:"topic",caption:"Physics",value:20,count:11},{group:"topic",caption:"Psychology",value:21,count:10},{group:"topic",caption:"Robotics",value:22,count:4},{group:"topic",caption:"Social Sciences",value:23,count:8},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:4}],offset:12,limit:12,total:0},popularBooks:{featuredBooks:[{type:"book",id:"10584",title:"Engineered Wood Products for Construction",subtitle:null,isOpenForSubmission:!1,hash:"421757c56a3735986055250821275a51",slug:"engineered-wood-products-for-construction",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10222",title:"Demyelination Disorders",subtitle:null,isOpenForSubmission:!1,hash:"b6c26ceccacdde70c41c587361bd5558",slug:"demyelination-disorders",bookSignature:"Stavros J. Baloyannis, Fabian H. Rossi and Welwin Liu",coverURL:"https://cdn.intechopen.com/books/images_new/10222.jpg",editors:[{id:"156098",title:"Emeritus Prof.",name:"Stavros J.",middleName:"J.",surname:"Baloyannis",slug:"stavros-j.-baloyannis",fullName:"Stavros J. Baloyannis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9544",title:"Global Trade in the Emerging Business Environment",subtitle:null,isOpenForSubmission:!1,hash:"fb8cb09b9599246add78d508a98273d5",slug:"global-trade-in-the-emerging-business-environment",bookSignature:"Muhammad Mohiuddin, Jingbin Wang , Md. Samim Al Azad and Selim Ahmed",coverURL:"https://cdn.intechopen.com/books/images_new/9544.jpg",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10979",title:"Parenting",subtitle:"Challenges of Child Rearing in a Changing Society",isOpenForSubmission:!1,hash:"6f345ebcf4fd61e73643c69063a12c7b",slug:"parenting-challenges-of-child-rearing-in-a-changing-society",bookSignature:"Sayyed Ali Samadi",coverURL:"https://cdn.intechopen.com/books/images_new/10979.jpg",editors:[{id:"52145",title:"Dr.",name:"Sayyed Ali",middleName:null,surname:"Samadi",slug:"sayyed-ali-samadi",fullName:"Sayyed Ali Samadi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9808",title:"Contemporary Topics in Patient Safety",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"fb6371607c2c6c02c6a2af8892765aba",slug:"contemporary-topics-in-patient-safety-volume-1",bookSignature:"Stanislaw P. Stawicki and Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/9808.jpg",editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10681",title:"Biodegradation Technology of Organic and Inorganic Pollutants",subtitle:null,isOpenForSubmission:!1,hash:"9a6e10e02788092872fd249436898e97",slug:"biodegradation-technology-of-organic-and-inorganic-pollutants",bookSignature:"Kassio Ferreira Mendes, Rodrigo Nogueira de Sousa and Kamila Cabral Mielke",coverURL:"https://cdn.intechopen.com/books/images_new/10681.jpg",editors:[{id:"197720",title:"Ph.D.",name:"Kassio",middleName:null,surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10764",title:"Antenna Systems",subtitle:null,isOpenForSubmission:!1,hash:"2fbf1c7a5d92723f08198fc9b526a8ad",slug:"antenna-systems",bookSignature:"Hussain Al-Rizzo and Said Abushamleh",coverURL:"https://cdn.intechopen.com/books/images_new/10764.jpg",editors:[{id:"153384",title:"Prof.",name:"Hussain",middleName:null,surname:"Al-Rizzo",slug:"hussain-al-rizzo",fullName:"Hussain Al-Rizzo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10668",title:"Sustainability of Concrete With Synthetic and Recycled Aggregates",subtitle:null,isOpenForSubmission:!1,hash:"55856c6a8bc3a5b21dae5a1af09a56b6",slug:"sustainability-of-concrete-with-synthetic-and-recycled-aggregates",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/10668.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam",middleName:null,surname:"Saleh",slug:"hosam-saleh",fullName:"Hosam Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,isOpenForSubmission:!1,hash:"176adcf090fdd1f93cb8ce3146e79ca1",slug:"reactive-oxygen-species",bookSignature:"Rizwan Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9032",title:"Corporate Social Responsibility",subtitle:null,isOpenForSubmission:!1,hash:"f609bf3251d7cc7bae0099a4374adfc3",slug:"corporate-social-responsibility",bookSignature:"Beatrice Orlando",coverURL:"https://cdn.intechopen.com/books/images_new/9032.jpg",editors:[{id:"232969",title:"Prof.",name:"Beatrice",middleName:null,surname:"Orlando",slug:"beatrice-orlando",fullName:"Beatrice Orlando"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10351",title:"Enhanced Liposuction",subtitle:"New Perspectives and Techniques",isOpenForSubmission:!1,hash:"f08ed6de16da357614586c5b58ed4dfa",slug:"enhanced-liposuction-new-perspectives-and-techniques",bookSignature:"Diane Irvine Duncan",coverURL:"https://cdn.intechopen.com/books/images_new/10351.jpg",editors:[{id:"279869",title:"Dr.",name:"Diane Irvine",middleName:null,surname:"Duncan",slug:"diane-irvine-duncan",fullName:"Diane Irvine Duncan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10779",title:"21st Century Nanostructured Materials",subtitle:"Physics, Chemistry, Classification, and Emerging Applications in Industry, Biomedicine, and Agriculture",isOpenForSubmission:!1,hash:"72c67f97f9bef68200df115b5fd79884",slug:"21st-century-nanostructured-materials-physics-chemistry-classification-and-emerging-applications-in-industry-biomedicine-and-agriculture",bookSignature:"Phuong V. Pham",coverURL:"https://cdn.intechopen.com/books/images_new/10779.jpg",editors:[{id:"236073",title:"Dr.",name:"Phuong",middleName:"Viet",surname:"Pham",slug:"phuong-pham",fullName:"Phuong Pham"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4386},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10584",title:"Engineered Wood Products for Construction",subtitle:null,isOpenForSubmission:!1,hash:"421757c56a3735986055250821275a51",slug:"engineered-wood-products-for-construction",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",publishedDate:"April 28th 2022",numberOfDownloads:3665,editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10222",title:"Demyelination Disorders",subtitle:null,isOpenForSubmission:!1,hash:"b6c26ceccacdde70c41c587361bd5558",slug:"demyelination-disorders",bookSignature:"Stavros J. Baloyannis, Fabian H. Rossi and Welwin Liu",coverURL:"https://cdn.intechopen.com/books/images_new/10222.jpg",publishedDate:"May 4th 2022",numberOfDownloads:1713,editors:[{id:"156098",title:"Emeritus Prof.",name:"Stavros J.",middleName:"J.",surname:"Baloyannis",slug:"stavros-j.-baloyannis",fullName:"Stavros J. Baloyannis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9544",title:"Global Trade in the Emerging Business Environment",subtitle:null,isOpenForSubmission:!1,hash:"fb8cb09b9599246add78d508a98273d5",slug:"global-trade-in-the-emerging-business-environment",bookSignature:"Muhammad Mohiuddin, Jingbin Wang , Md. Samim Al Azad and Selim Ahmed",coverURL:"https://cdn.intechopen.com/books/images_new/9544.jpg",publishedDate:"April 28th 2022",numberOfDownloads:2481,editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10979",title:"Parenting",subtitle:"Challenges of Child Rearing in a Changing Society",isOpenForSubmission:!1,hash:"6f345ebcf4fd61e73643c69063a12c7b",slug:"parenting-challenges-of-child-rearing-in-a-changing-society",bookSignature:"Sayyed Ali Samadi",coverURL:"https://cdn.intechopen.com/books/images_new/10979.jpg",publishedDate:"May 4th 2022",numberOfDownloads:1107,editors:[{id:"52145",title:"Dr.",name:"Sayyed Ali",middleName:null,surname:"Samadi",slug:"sayyed-ali-samadi",fullName:"Sayyed Ali Samadi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9808",title:"Contemporary Topics in Patient Safety",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"fb6371607c2c6c02c6a2af8892765aba",slug:"contemporary-topics-in-patient-safety-volume-1",bookSignature:"Stanislaw P. Stawicki and Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/9808.jpg",publishedDate:"April 20th 2022",numberOfDownloads:3307,editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10681",title:"Biodegradation Technology of Organic and Inorganic Pollutants",subtitle:null,isOpenForSubmission:!1,hash:"9a6e10e02788092872fd249436898e97",slug:"biodegradation-technology-of-organic-and-inorganic-pollutants",bookSignature:"Kassio Ferreira Mendes, Rodrigo Nogueira de Sousa and Kamila Cabral Mielke",coverURL:"https://cdn.intechopen.com/books/images_new/10681.jpg",publishedDate:"April 20th 2022",numberOfDownloads:3266,editors:[{id:"197720",title:"Ph.D.",name:"Kassio",middleName:null,surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10764",title:"Antenna Systems",subtitle:null,isOpenForSubmission:!1,hash:"2fbf1c7a5d92723f08198fc9b526a8ad",slug:"antenna-systems",bookSignature:"Hussain Al-Rizzo and Said Abushamleh",coverURL:"https://cdn.intechopen.com/books/images_new/10764.jpg",publishedDate:"April 28th 2022",numberOfDownloads:1868,editors:[{id:"153384",title:"Prof.",name:"Hussain",middleName:null,surname:"Al-Rizzo",slug:"hussain-al-rizzo",fullName:"Hussain Al-Rizzo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10668",title:"Sustainability of Concrete With Synthetic and Recycled Aggregates",subtitle:null,isOpenForSubmission:!1,hash:"55856c6a8bc3a5b21dae5a1af09a56b6",slug:"sustainability-of-concrete-with-synthetic-and-recycled-aggregates",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/10668.jpg",publishedDate:"May 4th 2022",numberOfDownloads:856,editors:[{id:"144691",title:"Prof.",name:"Hosam",middleName:null,surname:"Saleh",slug:"hosam-saleh",fullName:"Hosam Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,isOpenForSubmission:!1,hash:"176adcf090fdd1f93cb8ce3146e79ca1",slug:"reactive-oxygen-species",bookSignature:"Rizwan Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",publishedDate:"April 28th 2022",numberOfDownloads:1704,editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9032",title:"Corporate Social Responsibility",subtitle:null,isOpenForSubmission:!1,hash:"f609bf3251d7cc7bae0099a4374adfc3",slug:"corporate-social-responsibility",bookSignature:"Beatrice Orlando",coverURL:"https://cdn.intechopen.com/books/images_new/9032.jpg",publishedDate:"March 16th 2022",numberOfDownloads:7489,editors:[{id:"232969",title:"Prof.",name:"Beatrice",middleName:null,surname:"Orlando",slug:"beatrice-orlando",fullName:"Beatrice Orlando"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"10251",title:"Plankton Communities",subtitle:null,isOpenForSubmission:!1,hash:"e11e441ca2d2d5f631b1b4704505cfb6",slug:"plankton-communities",bookSignature:"Leonel Pereira and Ana Marta Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/10251.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"279788",title:"Dr.",name:"Leonel",middleName:null,surname:"Pereira",slug:"leonel-pereira",fullName:"Leonel Pereira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10830",title:"Animal Feed Science and Nutrition",subtitle:"Production, Health and Environment",isOpenForSubmission:!1,hash:"79944fc8fbbaa329aed6fde388154832",slug:"animal-feed-science-and-nutrition-production-health-and-environment",bookSignature:"Amlan Kumar Patra",coverURL:"https://cdn.intechopen.com/books/images_new/10830.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"310962",title:"Dr.",name:"Amlan",middleName:"Kumar",surname:"Patra",slug:"amlan-patra",fullName:"Amlan Patra"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10853",title:"Recent Advances in Polynomials",subtitle:null,isOpenForSubmission:!1,hash:"9e8671bae09ccaa8b8e276c639a737fc",slug:"recent-advances-in-polynomials",bookSignature:"Kamal Shah",coverURL:"https://cdn.intechopen.com/books/images_new/10853.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"231748",title:"Dr.",name:"Kamal",middleName:null,surname:"Shah",slug:"kamal-shah",fullName:"Kamal Shah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10871",title:"Computed-Tomography (CT) Scan",subtitle:null,isOpenForSubmission:!1,hash:"966d8cf74fa27eea1b9cbc9a6ee94993",slug:"computed-tomography-ct-scan",bookSignature:"Reda R. Gharieb",coverURL:"https://cdn.intechopen.com/books/images_new/10871.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"225387",title:"Prof.",name:"Reda R.",middleName:"R.",surname:"Gharieb",slug:"reda-r.-gharieb",fullName:"Reda R. Gharieb"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10903",title:"Genetically Modified Plants and Beyond",subtitle:null,isOpenForSubmission:!1,hash:"4d7ed4faab99c92cd4d676dc86501df9",slug:"genetically-modified-plants-and-beyond",bookSignature:"Idah Sithole Niang",coverURL:"https://cdn.intechopen.com/books/images_new/10903.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"90172",title:"Prof.",name:"Idah",middleName:null,surname:"Sithole-Niang",slug:"idah-sithole-niang",fullName:"Idah Sithole-Niang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10904",title:"Fusarium",subtitle:"An Overview of the Genus",isOpenForSubmission:!1,hash:"49d9063e43f94bd1517d65fbc58b93c3",slug:"fusarium-an-overview-of-the-genus",bookSignature:"Seyed Mahyar Mirmajlessi",coverURL:"https://cdn.intechopen.com/books/images_new/10904.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"100573",title:"Dr.",name:"Seyed Mahyar",middleName:null,surname:"Mirmajlessi",slug:"seyed-mahyar-mirmajlessi",fullName:"Seyed Mahyar Mirmajlessi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10654",title:"Brain-Computer Interface",subtitle:null,isOpenForSubmission:!1,hash:"a5308884068cc53ed31c6baba756857f",slug:"brain-computer-interface",bookSignature:"Vahid Asadpour",coverURL:"https://cdn.intechopen.com/books/images_new/10654.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"165328",title:"Dr.",name:"Vahid",middleName:null,surname:"Asadpour",slug:"vahid-asadpour",fullName:"Vahid Asadpour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10676",title:"Recent Applications in Graph Theory",subtitle:null,isOpenForSubmission:!1,hash:"900c60742d224080732bd16bd25ccba8",slug:"recent-applications-in-graph-theory",bookSignature:"Harun Pirim",coverURL:"https://cdn.intechopen.com/books/images_new/10676.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"146092",title:"Dr.",name:"Harun",middleName:null,surname:"Pirim",slug:"harun-pirim",fullName:"Harun Pirim"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11196",title:"New Updates in E-Learning",subtitle:null,isOpenForSubmission:!1,hash:"6afaadf68e2a0a4b370ac5ceb5ca89c6",slug:"new-updates-in-e-learning",bookSignature:"Eduard Babulak",coverURL:"https://cdn.intechopen.com/books/images_new/11196.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"10086",title:"Prof.",name:"Eduard",middleName:null,surname:"Babulak",slug:"eduard-babulak",fullName:"Eduard Babulak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9974",title:"E-Learning and Digital Education in the Twenty-First Century",subtitle:null,isOpenForSubmission:!1,hash:"88b58d66e975df20425fc1dfd22d53aa",slug:"e-learning-and-digital-education-in-the-twenty-first-century",bookSignature:"M. Mahruf C. Shohel",coverURL:"https://cdn.intechopen.com/books/images_new/9974.jpg",editedByType:"Edited by",publishedDate:"May 18th 2022",editors:[{id:"94099",title:"Dr.",name:"M. Mahruf C.",middleName:null,surname:"Shohel",slug:"m.-mahruf-c.-shohel",fullName:"M. Mahruf C. Shohel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"954",title:"Thermodynamics",slug:"thermodynamics",parent:{id:"158",title:"Metals and Nonmetals",slug:"metals-and-nonmetals"},numberOfBooks:2,numberOfSeries:0,numberOfAuthorsAndEditors:61,numberOfWosCitations:7,numberOfCrossrefCitations:10,numberOfDimensionsCitations:15,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"954",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"8416",title:"Non-Equilibrium Particle Dynamics",subtitle:null,isOpenForSubmission:!1,hash:"2c3add7639dcd1cb442cb4313ea64e3a",slug:"non-equilibrium-particle-dynamics",bookSignature:"Albert S. Kim",coverURL:"https://cdn.intechopen.com/books/images_new/8416.jpg",editedByType:"Edited by",editors:[{id:"21045",title:"Prof.",name:"Albert S.",middleName:null,surname:"Kim",slug:"albert-s.-kim",fullName:"Albert S. Kim"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7661",title:"Heat and Mass Transfer",subtitle:"Advances in Science and Technology Applications",isOpenForSubmission:!1,hash:"c29b5c2ce24925a935ca52b8344fbb99",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",bookSignature:"Alfredo Iranzo",coverURL:"https://cdn.intechopen.com/books/images_new/7661.jpg",editedByType:"Edited by",editors:[{id:"67352",title:"Dr.",name:"Alfredo",middleName:null,surname:"Iranzo",slug:"alfredo-iranzo",fullName:"Alfredo Iranzo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:2,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"67726",doi:"10.5772/intechopen.86322",title:"CFD Simulation of Heat and Mass Transfer for Climate Control in Greenhouses",slug:"cfd-simulation-of-heat-and-mass-transfer-for-climate-control-in-greenhouses",totalDownloads:1120,totalCrossrefCites:3,totalDimensionsCites:3,abstract:"Greenhouse plant production involves a number of processes such as transpiration, condensation, photosynthesis, and climate control. Such processes, in turn, set off mass and heat transfer phenomena that influence not only the quality and quantity of crop production but also its environmental cost. While these processes have considerably been analyzed in separate, they strongly interact with one another. For instance, increased radiation (mainly thermal infrared) increases temperature, reduces humidity, consequently increases transpiration, and affects CO2 exchange as well as other reaction rates. Computational fluid dynamics (CFD) is a numerical tool with a solid physical basis which allows, through the construction of a computational model, to simulate the fluid flow environment. Heating, ventilation, and condensation have been analyzed in the greenhouse environment with CFD techniques. The current challenge is the interaction of these processes and their impact on the production system. The present work summarizes some CFD investigations carried out in this topic, in order to analyze the processes of heat and mass transfer in a greenhouse for agronomic purposes.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Cruz Ernesto Aguilar Rodriguez and Jorge Flores Velazquez",authors:[{id:"173578",title:"Dr.",name:"Jorge",middleName:null,surname:"Flores-Velazquez",slug:"jorge-flores-velazquez",fullName:"Jorge Flores-Velazquez"}]},{id:"66158",doi:"10.5772/intechopen.84706",title:"Numerical Solution to Two-Dimensional Freezing and Subsequent Defrosting of Logs",slug:"numerical-solution-to-two-dimensional-freezing-and-subsequent-defrosting-of-logs",totalDownloads:620,totalCrossrefCites:3,totalDimensionsCites:3,abstract:"Two-dimensional mutually connected mathematical models have been created, solved, and verified for the transient non-linear heat conduction in logs during their freezing and subsequent defrosting. The models reflect the influence of the internal sources of latent heat of both the free and bound water on the logs’ freezing process and also the impact of the temperature on the fiber saturation point of wood species, with whose participation the current values of the thermo-physical characteristics in each separate volume point of the subjected to freezing and subsequent defrosting logs are computed. The chapter presents solutions of the models with explicit form of the finite-difference method and their validation towards own experimental studies. Results from experimental and simulative investigation of 2D non-stationary temperature distribution in the longitudinal section of beech and pine logs with a diameter of 0.24 m and length of 0.48 m during their many hours freezing in a freezer and subsequent defrosting at room temperature are presented, visualized, and analyzed.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Nencho Deliiski and Natalia Tumbarkova",authors:[{id:"43040",title:"Prof.",name:"Nencho",middleName:"Stanev",surname:"Deliiski",slug:"nencho-deliiski",fullName:"Nencho Deliiski"},{id:"284649",title:"Dr.",name:"Natalia",middleName:"Yordanova",surname:"Tumbarkova",slug:"natalia-tumbarkova",fullName:"Natalia Tumbarkova"}]},{id:"67626",doi:"10.5772/intechopen.86738",title:"The Boundary Element Method for Fluctuating Active Colloids",slug:"the-boundary-element-method-for-fluctuating-active-colloids",totalDownloads:920,totalCrossrefCites:0,totalDimensionsCites:2,abstract:"The boundary element method (BEM) is a computational method particularly suited to solution of linear partial differential equations (PDEs), including the Laplace and Stokes equations, in complex geometries. The PDEs are formulated as boundary integral equations over bounding surfaces, which can be discretized for numerical solution. This manuscript reviews application of the BEM for simulation of the dynamics of “active” colloids that can self-propel through liquid solution. We introduce basic concepts and model equations for both catalytically active colloids and the “squirmer” model of a ciliated biological microswimmer. We review the foundations of the BEM for both the Laplace and Stokes equations, including the application to confined geometries, and the extension of the method to include thermal fluctuations of the colloid. Finally, we discuss recent and potential applications to research problems concerning active colloids. The aim of this review is to facilitate development and adoption of boundary element models that capture the interplay of deterministic and stochastic effects in the dynamics of active colloids.",book:{id:"8416",slug:"non-equilibrium-particle-dynamics",title:"Non-Equilibrium Particle Dynamics",fullTitle:"Non-Equilibrium Particle Dynamics"},signatures:"William E. Uspal",authors:[{id:"279308",title:"Prof.",name:"William",middleName:null,surname:"Uspal",slug:"william-uspal",fullName:"William Uspal"}]},{id:"66487",doi:"10.5772/intechopen.85735",title:"Mean Aspects Controlling Supercritical CO2 Precipitation Processes",slug:"mean-aspects-controlling-supercritical-co-sub-2-sub-precipitation-processes",totalDownloads:736,totalCrossrefCites:1,totalDimensionsCites:2,abstract:"The use of supercritical CO2 is an excellent alternative in extraction, particle precipitation, impregnation and reaction processes due to its special properties. Solubility of the compound in supercritical CO2 drives the precipitation process in different ways. In supercritical antisolvent process, mass and heat transfers, phase equilibria, nucleation, and growth of the compound to be precipitated are the main phenomena that should be taken into account. Mass transfer conditions the morphology and particle size of the final product. This transfer could be tuned altering operating conditions. Heat transfer in non-isothermal process influences on mixing step the size of generated microparticles. In rapid expansion of supercritical solution, phenomena as the phase change from supercritical to a CO2 gas flow, rapid mass transfer and crystallization of the compound, and expansion jet define the morphology and size of the final product. These phenomena a priori could be modulated tuning a large number of operating parameters through the experiments, but the correlations and modeling of these processes are necessary to clarify the relative importance of each one. Moreover, particle agglomeration in the expansion jet and CO2 condensation are determinant phenomena which should be avoided in order to conserve fine particles in the final product.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Antonio Montes, Clara Pereyra and Enrique J. Martínez de la Ossa",authors:[{id:"55991",title:"Mr.",name:"Antonio",middleName:null,surname:"Montes",slug:"antonio-montes",fullName:"Antonio Montes"},{id:"55992",title:"Dr.",name:"Clara",middleName:null,surname:"Pereyra",slug:"clara-pereyra",fullName:"Clara Pereyra"},{id:"55993",title:"Dr.",name:"Enrique",middleName:null,surname:"Martinez De La Ossa",slug:"enrique-martinez-de-la-ossa",fullName:"Enrique Martinez De La Ossa"}]},{id:"66317",doi:"10.5772/intechopen.85254",title:"Review Heat Transfer of Non-Newtonian Fluids in Agitated Tanks",slug:"review-heat-transfer-of-non-newtonian-fluids-in-agitated-tanks",totalDownloads:1001,totalCrossrefCites:1,totalDimensionsCites:1,abstract:"The heating and cooling of non-Newtonian liquids in tanks with mechanical impellers are operations commonly employed as chemical reactors, heat exchangers, distillers, extractors, thinners and decanters. In particular, the design of heat exchangers (jackets, helical coils, spiral coils and vertical tubular baffles) in tanks requires the prior knowledge of the rheology of the liquid for the calculation of the convection coefficients and the Reynolds number, in order to obtain the area thermal exchange. This chapter aimed to present the basic concepts of tanks with agitation, non-Newtonian liquids, hydrodynamics, heat transfer and, finally, with a practical design example for engineers and undergraduate students.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Vitor da Silva Rosa and Deovaldo de Moraes Júnior",authors:[{id:"187128",title:"Ph.D.",name:"Vitor",middleName:null,surname:"Rosa",slug:"vitor-rosa",fullName:"Vitor Rosa"},{id:"188792",title:"Dr.",name:"Deovaldo",middleName:null,surname:"Moraes Júnior",slug:"deovaldo-moraes-junior",fullName:"Deovaldo Moraes Júnior"}]}],mostDownloadedChaptersLast30Days:[{id:"66878",title:"Design of Industrial Falling Film Evaporators",slug:"design-of-industrial-falling-film-evaporators",totalDownloads:1753,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"The high performance evaporators are important for process industries such as food, desalination and refineries. The falling film evaporators have many advantages over flooded and vertical tubes that make them best candidate for processes industries application. The heat transfer area is the key parameter in designing of an evaporator and many correlations are available to estimate the size of tube bundle. Unfortunately, most of the correlation is available only for pure water and above 322 K saturation temperatures. Out of these conditions, the areas are designed by the extrapolation of existing correlations. We demonstrated that the actual heat transfer values are 2–3-fold higher at lower temperature and hence simple extrapolated estimation leads to inefficient and high capital cost design. We proposed an accurate heat transfer correlation for falling film evaporators that can capture both, low temperature evaporation and salt concentration effectively. It is also embedded with unique bubble-assisted evaporation parameter that can be only observed at low temperature and it enhances the heat transfer. The proposed correlation is applicable from 280 to 305 K saturation temperatures and feed water concentration ranges from 35,000 to 95,000 ppm. The uncertainty of measured data is less than 5% and RMS of regressed data is 3.5%. In this chapter, first part summarized the all available correlations and their limitations. In second part, falling film evaporation heat transfer coefficient (FFHTC) is proposed and model is developed. In the last part, experimentation is conducted and FFHTC developed and compared with conventional correlations.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Muhammad Wakil Shahzad, Muhammad Burhan and Kim Choon Ng",authors:[{id:"174208",title:"Dr.",name:"Muhammad Wakil",middleName:null,surname:"Shahzad",slug:"muhammad-wakil-shahzad",fullName:"Muhammad Wakil Shahzad"},{id:"249811",title:"Dr.",name:"Muhammad",middleName:null,surname:"Burhan",slug:"muhammad-burhan",fullName:"Muhammad Burhan"},{id:"254696",title:"Prof.",name:"Kim Choon",middleName:null,surname:"Ng",slug:"kim-choon-ng",fullName:"Kim Choon Ng"}]},{id:"66102",title:"Heat and Mass Transfer of Additive Manufacturing Processes for Metals",slug:"heat-and-mass-transfer-of-additive-manufacturing-processes-for-metals",totalDownloads:1302,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"Additive manufacturing (AM), a method in which a part is fabricated layer by layer from a digital design package, provides the potential to produce complex components at reduced cost and time. Many techniques (using many different names) have been developed to accomplish this via melting or solid-state joining. However, to date, only a handful can be used to produce metallic parts that fulfill the requirements of industrial applications. The thermal physics and weld pool behaviors in metal AM process have decisive influence on the deposition quality, the microstructure and service performance of the depositions. Accurate analysis and calculation of thermal processes and weld pool behaviors are of great significance to the metallurgy analysis, stress and deformation analysis, process control and process optimization etc. Numerical modeling is also a necessary way to turn welding from qualitative description and experience-based art into quantitative analysis- and science-based engineering branch. In this chapter, two techniques for producing metal parts are explored, with a focus on the thermal science of metal AM: fluid flow and heat transfer. Selective laser melting (SLM) is the one that is most widely used because it typically has the best resolution. Another is named metal fused-coated additive manufacturing (MFCAM) that is cost competitive and efficient in producing large and middle-complex components in aerospace applications.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Zhengying Wei and Jun Du",authors:[{id:"47614",title:"Prof.",name:"Zhengying",middleName:null,surname:"Wei",slug:"zhengying-wei",fullName:"Zhengying Wei"},{id:"282052",title:"Dr.",name:"Jun",middleName:null,surname:"Du",slug:"jun-du",fullName:"Jun Du"}]},{id:"66563",title:"Heat and Mass Transfer in Outward Convex Corrugated Tube Heat Exchangers",slug:"heat-and-mass-transfer-in-outward-convex-corrugated-tube-heat-exchangers",totalDownloads:1037,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Heat and mass transfer in outward convex corrugated tube heat exchangers is of significant importance for the optimization, fabrication, and application of outward convex corrugated tube heat exchangers. This chapter gives a deep investigation of the heat and mass transfer in outward convex corrugated tube heat exchangers. Based on the experimental setup developed, the performances of a novel outward convex corrugated tube heat exchanger are presented. Simulation methods are then used to detail the heat and mass transfer at tube side and shell side of the outward convex corrugated tube heat exchanger, and these include the flow structure, temperature distribution, and turbulence kinetic energy. Heat and mass transfer enhancements of the outward convex corrugated tube heat exchanger are also studied, and they are from tube side, shell side, and overall system aspects. Finally, multi-objective optimization of the outward convex corrugated tube heat exchanger is conducted to obtain the optimal performances through using Response Surface Methodology (RSM) and Non-dominated Sorting Genetic Algorithm (NSGA-II). Main conclusions and future outlook are then briefly stated and summarized. We firmly believe that the contents presented in this chapter can not only enrich the knowledge of heat exchangers but also develop methods for studying heat exchangers.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Huaizhi Han, Bingxi Li, Yaning Zhang, Quan Zhu and Ruitian Yu",authors:[{id:"23828",title:"Dr.",name:"Quan",middleName:null,surname:"Zhu",slug:"quan-zhu",fullName:"Quan Zhu"},{id:"148369",title:"Prof.",name:"Bingxi",middleName:null,surname:"Li",slug:"bingxi-li",fullName:"Bingxi Li"},{id:"196928",title:"Dr.",name:"Yaning",middleName:null,surname:"Zhang",slug:"yaning-zhang",fullName:"Yaning Zhang"},{id:"281875",title:"Prof.",name:"Huaizhi",middleName:null,surname:"Han",slug:"huaizhi-han",fullName:"Huaizhi Han"},{id:"282268",title:"Mr.",name:"Ruitian",middleName:null,surname:"Yu",slug:"ruitian-yu",fullName:"Ruitian Yu"}]},{id:"66317",title:"Review Heat Transfer of Non-Newtonian Fluids in Agitated Tanks",slug:"review-heat-transfer-of-non-newtonian-fluids-in-agitated-tanks",totalDownloads:1001,totalCrossrefCites:1,totalDimensionsCites:1,abstract:"The heating and cooling of non-Newtonian liquids in tanks with mechanical impellers are operations commonly employed as chemical reactors, heat exchangers, distillers, extractors, thinners and decanters. In particular, the design of heat exchangers (jackets, helical coils, spiral coils and vertical tubular baffles) in tanks requires the prior knowledge of the rheology of the liquid for the calculation of the convection coefficients and the Reynolds number, in order to obtain the area thermal exchange. This chapter aimed to present the basic concepts of tanks with agitation, non-Newtonian liquids, hydrodynamics, heat transfer and, finally, with a practical design example for engineers and undergraduate students.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Vitor da Silva Rosa and Deovaldo de Moraes Júnior",authors:[{id:"187128",title:"Ph.D.",name:"Vitor",middleName:null,surname:"Rosa",slug:"vitor-rosa",fullName:"Vitor Rosa"},{id:"188792",title:"Dr.",name:"Deovaldo",middleName:null,surname:"Moraes Júnior",slug:"deovaldo-moraes-junior",fullName:"Deovaldo Moraes Júnior"}]},{id:"65692",title:"Advances in Concentrated Solar Power: A Perspective of Heat Transfer",slug:"advances-in-concentrated-solar-power-a-perspective-of-heat-transfer",totalDownloads:1114,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"Solar energy has the potential to reduce the dependence on the dwindling supply of fossil fuels through concentrated solar power (CSP) technology. CSP plants utilize solar thermal energy to produce electrical energy based on different thermodynamic power cycles. Solar collectors, reflectors, receivers, thermal fluid, and turbines are the main components of each CSP plant and involve intensive heat transfer at all stages. This chapter illustrates the thermal characteristics of the main components used in CSP technology. In addition, the solar thermal fluid characteristics and its stable operational ranges are discussed in this chapter. Heat capacity, vapor pressure, volume expansion, density and viscosity of the thermal fluid should not differ significantly at different temperatures during various operation stages because these variations can cause failure in the system, which is designed at the fixed material properties. Currently, CSP technology is associated with a higher cost compared to the electricity generated through gas power plants. Many efforts are made to search for sustainable and inexpensive materials to minimize the cost of CSP. One critical issue faced by CSP technology is the intermittent nature of the sun. Modern CSP plants integrate thermal energy storage (TES) unit to smoothen the power production or to shift the production from peak sunshine hours to peak demand hours.",book:{id:"7661",slug:"heat-and-mass-transfer-advances-in-science-and-technology-applications",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Advances in Science and Technology Applications"},signatures:"Fadi Alnaimat and Yasir Rashid",authors:[{id:"151722",title:"Dr.",name:"Fadi",middleName:null,surname:"Alnaimat",slug:"fadi-alnaimat",fullName:"Fadi Alnaimat"},{id:"291252",title:"Mr.",name:"Yasir",middleName:null,surname:"Rashid",slug:"yasir-rashid",fullName:"Yasir Rashid"}]}],onlineFirstChaptersFilter:{topicId:"954",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:8,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:98,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:286,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:9,numberOfPublishedChapters:101,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:11,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:null,scope:"
\r\n\tTransforming our World: the 2030 Agenda for Sustainable Development endorsed by United Nations and 193 Member States, came into effect on Jan 1, 2016, to guide decision making and actions to the year 2030 and beyond. Central to this Agenda are 17 Goals, 169 associated targets and over 230 indicators that are reviewed annually. The vision envisaged in the implementation of the SDGs is centered on the five Ps: People, Planet, Prosperity, Peace and Partnership. This call for renewed focused efforts ensure we have a safe and healthy planet for current and future generations.
\r\n
\r\n\t
\r\n
\r\n\tThis Series focuses on covering research and applied research involving the five Ps through the following topics:
\r\n
\r\n\t
\r\n
\r\n\t1. Sustainable Economy and Fair Society that relates to SDG 1 on No Poverty, SDG 2 on Zero Hunger, SDG 8 on Decent Work and Economic Growth, SDG 10 on Reduced Inequalities, SDG 12 on Responsible Consumption and Production, and SDG 17 Partnership for the Goals
\r\n
\r\n\t
\r\n
\r\n\t2. Health and Wellbeing focusing on SDG 3 on Good Health and Wellbeing and SDG 6 on Clean Water and Sanitation
\r\n
\r\n\t
\r\n
\r\n\t3. Inclusivity and Social Equality involving SDG 4 on Quality Education, SDG 5 on Gender Equality, and SDG 16 on Peace, Justice and Strong Institutions
\r\n
\r\n\t
\r\n
\r\n\t4. Climate Change and Environmental Sustainability comprising SDG 13 on Climate Action, SDG 14 on Life Below Water, and SDG 15 on Life on Land
\r\n
\r\n\t
\r\n
\r\n\t5. Urban Planning and Environmental Management embracing SDG 7 on Affordable Clean Energy, SDG 9 on Industry, Innovation and Infrastructure, and SDG 11 on Sustainable Cities and Communities.
\r\n
\r\n\t
\r\n
\r\n\tThe series also seeks to support the use of cross cutting SDGs, as many of the goals listed above, targets and indicators are all interconnected to impact our lives and the decisions we make on a daily basis, making them impossible to tie to a single topic.
",coverUrl:"https://cdn.intechopen.com/series/covers/24.jpg",latestPublicationDate:"April 24th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:0,editor:{id:"262440",title:"Prof.",name:"Usha",middleName:null,surname:"Iyer-Raniga",slug:"usha-iyer-raniga",fullName:"Usha Iyer-Raniga",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRYSXQA4/Profile_Picture_2022-02-28T13:55:36.jpeg",biography:"Usha Iyer-Raniga is a professor in the School of Property and Construction Management at RMIT University. Usha co-leads the One Planet Network’s Sustainable Buildings and Construction Programme (SBC), a United Nations 10 Year Framework of Programmes on Sustainable Consumption and Production (UN 10FYP SCP) aligned with Sustainable Development Goal 12. The work also directly impacts SDG 11 on Sustainable Cities and Communities. She completed her undergraduate degree as an architect before obtaining her Masters degree from Canada and her Doctorate in Australia. Usha has been a keynote speaker as well as an invited speaker at national and international conferences, seminars and workshops. Her teaching experience includes teaching in Asian countries. She has advised Austrade, APEC, national, state and local governments. She serves as a reviewer and a member of the scientific committee for national and international refereed journals and refereed conferences. She is on the editorial board for refereed journals and has worked on Special Issues. Usha has served and continues to serve on the Boards of several not-for-profit organisations and she has also served as panel judge for a number of awards including the Premiers Sustainability Award in Victoria and the International Green Gown Awards. Usha has published over 100 publications, including research and consulting reports. Her publications cover a wide range of scientific and technical research publications that include edited books, book chapters, refereed journals, refereed conference papers and reports for local, state and federal government clients. She has also produced podcasts for various organisations and participated in media interviews. She has received state, national and international funding worth over USD $25 million. Usha has been awarded the Quarterly Franklin Membership by London Journals Press (UK). Her biography has been included in the Marquis Who's Who in the World® 2018, 2016 (33rd Edition), along with approximately 55,000 of the most accomplished men and women from around the world, including luminaries as U.N. Secretary-General Ban Ki-moon. In 2017, Usha was awarded the Marquis Who’s Who Lifetime Achiever Award.",institutionString:null,institution:{name:"RMIT University",institutionURL:null,country:{name:"Australia"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:4,paginationItems:[{id:"14",title:"Cell and Molecular Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",isOpenForSubmission:!0,editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",slug:"rosa-maria-martinez-espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",biography:"Dr. Rosa María Martínez-Espinosa has been a Spanish Full Professor since 2020 (Biochemistry and Molecular Biology) and is currently Vice-President of International Relations and Cooperation development and leader of the research group 'Applied Biochemistry” (University of Alicante, Spain). Other positions she has held at the university include Vice-Dean of Master Programs, Vice-Dean of the Degree in Biology and Vice-Dean for Mobility and Enterprise and Engagement at the Faculty of Science (University of Alicante). She received her Bachelor in Biology in 1998 (University of Alicante) and her PhD in 2003 (Biochemistry, University of Alicante). She undertook post-doctoral research at the University of East Anglia (Norwich, U.K. 2004-2005; 2007-2008).\nHer multidisciplinary research focuses on investigating archaea and their potential applications in biotechnology. She has an H-index of 21. She has authored one patent and has published more than 70 indexed papers and around 60 book chapters.\nShe has contributed to more than 150 national and international meetings during the last 15 years. Her research interests include archaea metabolism, enzymes purification and characterization, gene regulation, carotenoids and bioplastics production, antioxidant\ncompounds, waste water treatments, and brines bioremediation.\nRosa María’s other roles include editorial board member for several journals related\nto biochemistry, reviewer for more than 60 journals (biochemistry, molecular biology, biotechnology, chemistry and microbiology) and president of several organizing committees in international meetings related to the N-cycle or respiratory processes.",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null},{id:"15",title:"Chemical Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",isOpenForSubmission:!0,editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",slug:"sukru-beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",biography:"Dr. Şükrü Beydemir obtained a BSc in Chemistry in 1995 from Yüzüncü Yıl University, MSc in Biochemistry in 1998, and PhD in Biochemistry in 2002 from Atatürk University, Turkey. He performed post-doctoral studies at Max-Planck Institute, Germany, and University of Florence, Italy in addition to making several scientific visits abroad. He currently works as a Full Professor of Biochemistry in the Faculty of Pharmacy, Anadolu University, Turkey. Dr. Beydemir has published over a hundred scientific papers spanning protein biochemistry, enzymology and medicinal chemistry, reviews, book chapters and presented several conferences to scientists worldwide. He has received numerous publication awards from various international scientific councils. He serves in the Editorial Board of several international journals. Dr. Beydemir is also Rector of Bilecik Şeyh Edebali University, Turkey.",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",slug:"deniz-ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",biography:"Dr. Deniz Ekinci obtained a BSc in Chemistry in 2004, MSc in Biochemistry in 2006, and PhD in Biochemistry in 2009 from Atatürk University, Turkey. He studied at Stetson University, USA, in 2007-2008 and at the Max Planck Institute of Molecular Cell Biology and Genetics, Germany, in 2009-2010. Dr. Ekinci currently works as a Full Professor of Biochemistry in the Faculty of Agriculture and is the Head of the Enzyme and Microbial Biotechnology Division, Ondokuz Mayıs University, Turkey. He is a member of the Turkish Biochemical Society, American Chemical Society, and German Genetics society. Dr. Ekinci published around ninety scientific papers, reviews and book chapters, and presented several conferences to scientists. He has received numerous publication awards from several scientific councils. Dr. Ekinci serves as the Editor in Chief of four international books and is involved in the Editorial Board of several international journals.",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null},{id:"17",title:"Metabolism",coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",isOpenForSubmission:!0,editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",slug:"yannis-karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",biography:"Yannis Karamanos, born in Greece in 1953, completed his pre-graduate studies at the Université Pierre et Marie Curie, Paris, then his Masters and Doctoral degree at the Université de Lille (1983). He was associate professor at the University of Limoges (1987) before becoming full professor of biochemistry at the Université d’Artois (1996). He worked on the structure-function relationships of glycoconjugates and his main project was the investigations on the biological roles of the de-N-glycosylation enzymes (Endo-N-acetyl-β-D-glucosaminidase and peptide-N4-(N-acetyl-β-glucosaminyl) asparagine amidase). From 2002 he contributes to the understanding of the Blood-brain barrier functioning using proteomics approaches. He has published more than 70 papers. His teaching areas are energy metabolism and regulation, integration and organ specialization and metabolic adaptation.",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null},{id:"18",title:"Proteomics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",isOpenForSubmission:!0,editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",slug:"paolo-iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",biography:"Paolo Iadarola graduated with a degree in Chemistry from the University of Pavia (Italy) in July 1972. He then worked as an Assistant Professor at the Faculty of Science of the same University until 1984. In 1985, Prof. Iadarola became Associate Professor at the Department of Biology and Biotechnologies of the University of Pavia and retired in October 2017. Since then, he has been working as an Adjunct Professor in the same Department at the University of Pavia. His research activity during the first years was primarily focused on the purification and structural characterization of enzymes from animal and plant sources. During this period, Prof. Iadarola familiarized himself with the conventional techniques used in column chromatography, spectrophotometry, manual Edman degradation, and electrophoresis). Since 1995, he has been working on: i) the determination in biological fluids (serum, urine, bronchoalveolar lavage, sputum) of proteolytic activities involved in the degradation processes of connective tissue matrix, and ii) on the identification of biological markers of lung diseases. In this context, he has developed and validated new methodologies (e.g., Capillary Electrophoresis coupled to Laser-Induced Fluorescence, CE-LIF) whose application enabled him to determine both the amounts of biochemical markers (Desmosines) in urine/serum of patients affected by Chronic Obstructive Pulmonary Disease (COPD) and the activity of proteolytic enzymes (Human Neutrophil Elastase, Cathepsin G, Pseudomonas aeruginosa elastase) in sputa of these patients. More recently, Prof. Iadarola was involved in developing techniques such as two-dimensional electrophoresis coupled to liquid chromatography/mass spectrometry (2DE-LC/MS) for the proteomic analysis of biological fluids aimed at the identification of potential biomarkers of different lung diseases. He is the author of about 150 publications (According to Scopus: H-Index: 23; Total citations: 1568- According to WOS: H-Index: 20; Total Citations: 1296) of peer-reviewed international journals. He is a Consultant Reviewer for several journals, including the Journal of Chromatography A, Journal of Chromatography B, Plos ONE, Proteomes, International Journal of Molecular Science, Biotech, Electrophoresis, and others. He is also Associate Editor of Biotech.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",slug:"simona-viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",biography:"Simona Viglio is an Associate Professor of Biochemistry at the Department of Molecular Medicine at the University of Pavia. She has been working since 1995 on the determination of proteolytic enzymes involved in the degradation process of connective tissue matrix and on the identification of biological markers of lung diseases. She gained considerable experience in developing and validating new methodologies whose applications allowed her to determine both the amount of biomarkers (Desmosine and Isodesmosine) in the urine of patients affected by COPD, and the activity of proteolytic enzymes (HNE, Cathepsin G, Pseudomonas aeruginosa elastase) in the sputa of these patients. Simona Viglio was also involved in research dealing with the supplementation of amino acids in patients with brain injury and chronic heart failure. She is presently engaged in the development of 2-DE and LC-MS techniques for the study of proteomics in biological fluids. The aim of this research is the identification of potential biomarkers of lung diseases. She is an author of about 90 publications (According to Scopus: H-Index: 23; According to WOS: H-Index: 20) on peer-reviewed journals, a member of the “Società Italiana di Biochimica e Biologia Molecolare,“ and a Consultant Reviewer for International Journal of Molecular Science, Journal of Chromatography A, COPD, Plos ONE and Nutritional Neuroscience.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:49,paginationItems:[{id:"80495",title:"Iron in Cell Metabolism and Disease",doi:"10.5772/intechopen.101908",signatures:"Eeka Prabhakar",slug:"iron-in-cell-metabolism-and-disease",totalDownloads:0,totalCrossrefCites:null,totalDimensionsCites:null,authors:null,book:{title:"Iron Metabolism - Iron a Double‐Edged Sword",coverURL:"https://cdn.intechopen.com/books/images_new/10842.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81799",title:"Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases",doi:"10.5772/intechopen.104978",signatures:"Richa Rai",slug:"cross-talk-of-purinergic-and-immune-signaling-implication-in-inflammatory-and-pathogenic-diseases",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81764",title:"Involvement of the Purinergic System in Cell Death in Models of Retinopathies",doi:"10.5772/intechopen.103935",signatures:"Douglas Penaforte Cruz, Marinna Garcia Repossi and Lucianne Fragel Madeira",slug:"involvement-of-the-purinergic-system-in-cell-death-in-models-of-retinopathies",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81756",title:"Alteration of Cytokines Level and Oxidative Stress Parameters in COVID-19",doi:"10.5772/intechopen.104950",signatures:"Marija Petrusevska, Emilija Atanasovska, Dragica Zendelovska, Aleksandar Eftimov and Katerina Spasovska",slug:"alteration-of-cytokines-level-and-oxidative-stress-parameters-in-covid-19",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Chemokines Updates",coverURL:"https://cdn.intechopen.com/books/images_new/11672.jpg",subseries:{id:"18",title:"Proteomics"}}}]},overviewPagePublishedBooks:{paginationCount:27,paginationItems:[{type:"book",id:"7006",title:"Biochemistry and Health Benefits of Fatty Acids",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7006.jpg",slug:"biochemistry-and-health-benefits-of-fatty-acids",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Viduranga Waisundara",hash:"c93a00abd68b5eba67e5e719f67fd20b",volumeInSeries:1,fullTitle:"Biochemistry and Health Benefits of Fatty Acids",editors:[{id:"194281",title:"Dr.",name:"Viduranga Y.",middleName:null,surname:"Waisundara",slug:"viduranga-y.-waisundara",fullName:"Viduranga Y. Waisundara",profilePictureURL:"https://mts.intechopen.com/storage/users/194281/images/system/194281.jpg",biography:"Dr. Viduranga Waisundara obtained her Ph.D. in Food Science and Technology from the Department of Chemistry, National University of Singapore, in 2010. She was a lecturer at Temasek Polytechnic, Singapore from July 2009 to March 2013. She relocated to her motherland of Sri Lanka and spearheaded the Functional Food Product Development Project at the National Institute of Fundamental Studies from April 2013 to October 2016. She was a senior lecturer on a temporary basis at the Department of Food Technology, Faculty of Technology, Rajarata University of Sri Lanka. She is currently Deputy Principal of the Australian College of Business and Technology – Kandy Campus, Sri Lanka. She is also the Global Harmonization Initiative (GHI) Ambassador to Sri Lanka.",institutionString:"Australian College of Business & Technology",institution:null}]},{type:"book",id:"6820",title:"Keratin",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6820.jpg",slug:"keratin",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Miroslav Blumenberg",hash:"6def75cd4b6b5324a02b6dc0359896d0",volumeInSeries:2,fullTitle:"Keratin",editors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}}]},{type:"book",id:"7978",title:"Vitamin A",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7978.jpg",slug:"vitamin-a",publishedDate:"May 15th 2019",editedByType:"Edited by",bookSignature:"Leila Queiroz Zepka, Veridiana Vera de Rosso and Eduardo Jacob-Lopes",hash:"dad04a658ab9e3d851d23705980a688b",volumeInSeries:3,fullTitle:"Vitamin A",editors:[{id:"261969",title:"Dr.",name:"Leila",middleName:null,surname:"Queiroz Zepka",slug:"leila-queiroz-zepka",fullName:"Leila Queiroz Zepka",profilePictureURL:"https://mts.intechopen.com/storage/users/261969/images/system/261969.png",biography:"Prof. Dr. Leila Queiroz Zepka is currently an associate professor in the Department of Food Technology and Science, Federal University of Santa Maria, Brazil. She has more than fifteen years of teaching and research experience. She has published more than 550 scientific publications/communications, including 15 books, 50 book chapters, 100 original research papers, 380 research communications in national and international conferences, and 12 patents. She is a member of the editorial board of five journals and acts as a reviewer for several national and international journals. Her research interests include microalgal biotechnology with an emphasis on microalgae-based products.",institutionString:"Universidade Federal de Santa Maria",institution:{name:"Universidade Federal de Santa Maria",institutionURL:null,country:{name:"Brazil"}}}]},{type:"book",id:"7953",title:"Bioluminescence",subtitle:"Analytical Applications and Basic Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7953.jpg",slug:"bioluminescence-analytical-applications-and-basic-biology",publishedDate:"September 25th 2019",editedByType:"Edited by",bookSignature:"Hirobumi Suzuki",hash:"3a8efa00b71abea11bf01973dc589979",volumeInSeries:4,fullTitle:"Bioluminescence - Analytical Applications and Basic Biology",editors:[{id:"185746",title:"Dr.",name:"Hirobumi",middleName:null,surname:"Suzuki",slug:"hirobumi-suzuki",fullName:"Hirobumi Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/185746/images/system/185746.png",biography:"Dr. Hirobumi Suzuki received his Ph.D. in 1997 from Tokyo Metropolitan University, Japan, where he studied firefly phylogeny and the evolution of mating systems. He is especially interested in the genetic differentiation pattern and speciation process that correlate to the flashing pattern and mating behavior of some fireflies in Japan. He then worked for Olympus Corporation, a Japanese manufacturer of optics and imaging products, where he was involved in the development of luminescence technology and produced a bioluminescence microscope that is currently being used for gene expression analysis in chronobiology, neurobiology, and developmental biology. Dr. Suzuki currently serves as a visiting researcher at Kogakuin University, Japan, and also a vice president of the Japan Firefly Society.",institutionString:"Kogakuin University",institution:null}]}]},openForSubmissionBooks:{paginationCount:6,paginationItems:[{id:"11667",title:"Marine Pollution - Recent Developments",coverURL:"https://cdn.intechopen.com/books/images_new/11667.jpg",hash:"e524cd97843b075a724e151256773631",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"April 20th 2022",isOpenForSubmission:!0,editors:[{id:"318562",title:"Dr.",name:"Monique",surname:"Mancuso",slug:"monique-mancuso",fullName:"Monique Mancuso"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11664",title:"Recent Advances in Sensing Technologies for Environmental Control and Monitoring",coverURL:"https://cdn.intechopen.com/books/images_new/11664.jpg",hash:"cf1ee76443e393bc7597723c3ee3e26f",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"May 4th 2022",isOpenForSubmission:!0,editors:[{id:"24687",title:"Dr.",name:"Toonika",surname:"Rinken",slug:"toonika-rinken",fullName:"Toonika Rinken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11662",title:"Limnology - The Importance of Monitoring and Correlations of Lentic and Lotic Waters",coverURL:"https://cdn.intechopen.com/books/images_new/11662.jpg",hash:"f1043cf6b1daae7a7b527e1d162ca4a8",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"May 10th 2022",isOpenForSubmission:!0,editors:[{id:"315689",title:"Dr.",name:"Carmine",surname:"Massarelli",slug:"carmine-massarelli",fullName:"Carmine Massarelli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"10845",title:"Marine Ecosystems - Biodiversity, Ecosystem Services and Human Impacts",coverURL:"https://cdn.intechopen.com/books/images_new/10845.jpg",hash:"727e7eb3d4ba529ec5eb4f150e078523",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"May 12th 2022",isOpenForSubmission:!0,editors:[{id:"320124",title:"Dr.",name:"Ana M.M.",surname:"Gonçalves",slug:"ana-m.m.-goncalves",fullName:"Ana M.M. Gonçalves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11665",title:"Recent Advances in Wildlife Management",coverURL:"https://cdn.intechopen.com/books/images_new/11665.jpg",hash:"73da0df494a1a56ab9c4faf2ee811899",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"May 25th 2022",isOpenForSubmission:!0,editors:[{id:"75563",title:"Dr.",name:"Farzana Khan",surname:"Perveen",slug:"farzana-khan-perveen",fullName:"Farzana Khan Perveen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11666",title:"Soil Contamination - Recent Advances and Future Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11666.jpg",hash:"c8890038b86fb6e5af16ea3c22669ae9",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"June 9th 2022",isOpenForSubmission:!0,editors:[{id:"299110",title:"Dr.",name:"Adnan",surname:"Mustafa",slug:"adnan-mustafa",fullName:"Adnan Mustafa"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:43,paginationItems:[{id:"81796",title:"Apoptosis-Related Diseases and Peroxisomes",doi:"10.5772/intechopen.105052",signatures:"Meimei Wang, Yakun Liu, Ni Chen, Juan Wang and Ye Zhao",slug:"apoptosis-related-diseases-and-peroxisomes",totalDownloads:2,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81723",title:"Peroxisomal Modulation as Therapeutic Alternative for Tackling Multiple Cancers",doi:"10.5772/intechopen.104873",signatures:"Shazia Usmani, Shadma Wahab, Abdul Hafeez, Shabana Khatoon and Syed Misbahul Hasan",slug:"peroxisomal-modulation-as-therapeutic-alternative-for-tackling-multiple-cancers",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81638",title:"Aging and Neuropsychiatric Disease: A General Overview of Prevalence and Trends",doi:"10.5772/intechopen.103102",signatures:"Jelena Milić",slug:"aging-and-neuropsychiatric-disease-a-general-overview-of-prevalence-and-trends",totalDownloads:14,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Senescence",coverURL:"https://cdn.intechopen.com/books/images_new/10935.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81566",title:"New and Emerging Technologies for Integrative Ambulatory Autonomic Assessment and Intervention as a Catalyst in the Synergy of Remote Geocoded Biosensing, Algorithmic Networked Cloud Computing, Deep Learning, and Regenerative/Biomic Medicine: Further Real",doi:"10.5772/intechopen.104092",signatures:"Robert L. Drury",slug:"new-and-emerging-technologies-for-integrative-ambulatory-autonomic-assessment-and-intervention-as-a-",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"81576",title:"Carotenoids in Thermal Adaptation of Plants and Animals",doi:"10.5772/intechopen.104537",signatures:"Ivan M. Petyaev",slug:"carotenoids-in-thermal-adaptation-of-plants-and-animals",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Ivan",surname:"Petyaev"}],book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81358",title:"New Insights on Carotenoid Production by Gordonia alkanivorans Strain 1B",doi:"10.5772/intechopen.103919",signatures:"Tiago P. Silva, Susana M. Paixão, Ana S. Fernandes, José C. Roseiro and Luís Alves",slug:"new-insights-on-carotenoid-production-by-gordonia-alkanivorans-strain-1b",totalDownloads:13,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81298",title:"Roles of Extracellular Vesicles in Cancer Metastasis",doi:"10.5772/intechopen.103798",signatures:"Eman Helmy Thabet",slug:"roles-of-extracellular-vesicles-in-cancer-metastasis",totalDownloads:20,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Extracellular Vesicles - Role in Diseases Pathogenesis and Therapy",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81290",title:"Musculoskeletal Abnormalities Caused by Cystic Fibrosis",doi:"10.5772/intechopen.104591",signatures:"Mark Lambrechts",slug:"musculoskeletal-abnormalities-caused-by-cystic-fibrosis",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Advances in Skeletal Muscle Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/11675.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81286",title:"Potassium Derangements: A Pathophysiological Review, Diagnostic Approach, and Clinical Management",doi:"10.5772/intechopen.103016",signatures:"Sairah Sharif and Jie Tang",slug:"potassium-derangements-a-pathophysiological-review-diagnostic-approach-and-clinical-management",totalDownloads:24,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Potassium in Human Health",coverURL:"https://cdn.intechopen.com/books/images_new/10794.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"81246",title:"Role of Carotenoids in Cardiovascular Disease",doi:"10.5772/intechopen.102750",signatures:"Arslan Ahmad, Sakhawat Riaz, Muhammad Shahzaib Nadeem, Umber Mubeen and Khadija Maham",slug:"role-of-carotenoids-in-cardiovascular-disease",totalDownloads:26,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}}]},subseriesFiltersForOFChapters:[{caption:"Plant Physiology",value:13,count:5,group:"subseries"},{caption:"Human Physiology",value:12,count:13,group:"subseries"},{caption:"Cell Physiology",value:11,count:25,group:"subseries"}],publishedBooks:{paginationCount:0,paginationItems:[]},subseriesFiltersForPublishedBooks:[],publicationYearFilters:[],authors:{paginationCount:25,paginationItems:[{id:"429683",title:"Dr.",name:"Bilal",middleName:null,surname:"Khalid",slug:"bilal-khalid",fullName:"Bilal Khalid",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/429683/images/system/429683.png",biography:"Dr. Bilal Khalid received a Ph.D. in Industrial Business Administration from KMITL Business School, Bangkok, in 2021, and a master’s in International Business Management from Stamford International University, Bangkok, in 2017. Dr. Khalid\\'s research interests include leadership and negotiations, digital transformations, gamification, eLearning, blockchain, Big Data, and management of information technology. Dr. Bilal Khalid also serves as an academic editor at Education Research International and a reviewer for international journals.",institutionString:"KMITL Business School",institution:{name:"King Mongkut's Institute of Technology Ladkrabang",country:{name:"Thailand"}}},{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",biography:"Dr. Muhammad Mohiuddin is an Associate Professor of International Business at Laval University, Canada. He has taught at Thompson Rivers University, Canada; University of Paris-Est, France; Osnabruck University of Applied Science, Germany; and Shanghai Institute of Technology and Tianjin University of Technology, China. He has published research in Research Policy, Applied Economics, Review of Economic Philosophy, Strategic Change, International Journal of Logistics, Sustainability, Journal of Environmental Management, Journal of Global Information Management, Journal of Cleaner Production, M@N@GEMENT, and more. He is a member of CEDIMES Institut (France), Academy of International Business (AIB), Strategic Management Society (SMS), Academy of Management (AOM), Administrative Science Association of Canada (ASAC), and Canadian council of small business and entrepreneurship (CCSBE). He is currently the director of the Research Group on Contemporary Asia (GERAC) at Laval University. He is also co-managing editor of Transnational Corporations Review and a guest editor for Electronic Commerce Research and Journal of Internet Technology.",institutionString:null,institution:{name:"Université Laval",country:{name:"Canada"}}},{id:"189147",title:"Dr.",name:"Hailan",middleName:null,surname:"Salamun",slug:"hailan-salamun",fullName:"Hailan Salamun",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/189147/images/19274_n.jpeg",biography:"Hailan Salamun, (Dr.) was born in Selangor, Malaysia and graduated from Tunku Ampuan Jamaah Religious High School at Shah Alam. Obtained a degree from the International Islamic University (UIA), Gombak in the field of Islamic Revealed Knowledge and Heritage. Next, I furthered my studies to the professional level to obtain a Diploma in Education at UIA. After serving for several years in school, I furthered my studies to the Master of Dakwah and Leadership at Universiti Kebangsaan Malaysia (UKM), Bangi. I graduated with a Doctor of Philosophy in Principalship Leadership from the University of Malaya (UM) in 2010. I am currently a senior lecturer in the Department of Nationalism and Civilization, Center for Basic and Continuing Education, Universiti Malaysia Terengganu. Prior to that, I had served in several educational institutions such as schools, the Institute of Teacher Education (IPG), and also the University of Malaya. I am also actively involved in paper presentation, writing and publishing. My research interests are focused on leadership, education, society and Islamic civilization. This area of research requires a detailed understanding of Islamic studies and research studies in leadership. Another research interest that I have explored recently is the politics of the Malay community and also the leadership of the mosque.",institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"442081",title:"Dr.",name:"Audrey",middleName:null,surname:"Addy",slug:"audrey-addy",fullName:"Audrey Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Kwame Nkrumah University of Science and Technology",country:{name:"Ghana"}}},{id:"437993",title:"Mr.",name:"Job",middleName:null,surname:"Jackson",slug:"job-jackson",fullName:"Job Jackson",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Management College of Southern Africa",country:{name:"South Africa"}}},{id:"428495",title:"Prof.",name:"Asyraf",middleName:null,surname:"Ab Rahman",slug:"asyraf-ab-rahman",fullName:"Asyraf Ab Rahman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"429650",title:"Dr.",name:"Jacqueline",middleName:null,surname:"Kareem",slug:"jacqueline-kareem",fullName:"Jacqueline Kareem",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Christ University",country:{name:"India"}}},{id:"421041",title:"Dr.",name:"Sunil",middleName:null,surname:"Kumar Ramdas",slug:"sunil-kumar-ramdas",fullName:"Sunil Kumar Ramdas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Jain University",country:{name:"India"}}},{id:"421833",title:"Mr.",name:"Eugene",middleName:null,surname:"Owusu-Acheampong",slug:"eugene-owusu-acheampong",fullName:"Eugene Owusu-Acheampong",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Ghana",country:{name:"Ghana"}}},{id:"239876",title:"Ph.D.",name:"Luciana",middleName:null,surname:"Mourão",slug:"luciana-mourao",fullName:"Luciana Mourão",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Salgado de Oliveira",country:{name:"Brazil"}}},{id:"421735",title:"Dr.",name:"elizabeth",middleName:null,surname:"addy",slug:"elizabeth-addy",fullName:"elizabeth addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"442083",title:"Dr.",name:"James",middleName:null,surname:"Addy",slug:"james-addy",fullName:"James Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437991",title:"Prof.",name:"Muhammad",middleName:null,surname:"Hoque",slug:"muhammad-hoque",fullName:"Muhammad Hoque",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421006",title:"Dr.",name:"Anna",middleName:null,surname:"Uster",slug:"anna-uster",fullName:"Anna Uster",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470243",title:"Dr.",name:"Md Samim",middleName:null,surname:"Al Azad",slug:"md-samim-al-azad",fullName:"Md Samim Al Azad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470244",title:"Dr.",name:"Slimane",middleName:null,surname:"Ed-dafali",slug:"slimane-ed-dafali",fullName:"Slimane Ed-dafali",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421011",title:"Dr.",name:"Afatakpa",middleName:null,surname:"Fortune",slug:"afatakpa-fortune",fullName:"Afatakpa Fortune",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"446057",title:"Mr.",name:"Okedare",middleName:null,surname:"David Olubukunmi",slug:"okedare-david-olubukunmi",fullName:"Okedare David Olubukunmi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421778",title:"Dr.",name:"Fatimah",middleName:"Saeed",surname:"AlAhmari",slug:"fatimah-alahmari",fullName:"Fatimah AlAhmari",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421024",title:"Prof.",name:"Harold Andrew",middleName:null,surname:"Patrick",slug:"harold-andrew-patrick",fullName:"Harold Andrew Patrick",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421065",title:"Ms.",name:"Euzália",middleName:null,surname:"do Rosário Botelho Tomé",slug:"euzalia-do-rosario-botelho-tome",fullName:"Euzália do Rosário Botelho Tomé",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421053",title:"Associate Prof.",name:"Ken",middleName:null,surname:"Kalala Ndalamba",slug:"ken-kalala-ndalamba",fullName:"Ken Kalala Ndalamba",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421826",title:"Dr.",name:"Inusah",middleName:null,surname:"Salifu",slug:"inusah-salifu",fullName:"Inusah Salifu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"420823",title:"Prof.",name:"Gardênia da Silva",middleName:null,surname:"Abbad",slug:"gardenia-da-silva-abbad",fullName:"Gardênia da Silva Abbad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437613",title:"MSc.",name:"Juliana",middleName:null,surname:"Legentil",slug:"juliana-legentil",fullName:"Juliana Legentil",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]}},subseries:{item:{id:"12",type:"subseries",title:"Human Physiology",keywords:"Anatomy, Cells, Organs, Systems, Homeostasis, Functions",scope:"Human physiology is the scientific exploration of the various functions (physical, biochemical, and mechanical properties) of humans, their organs, and their constituent cells. The endocrine and nervous systems play important roles in maintaining homeostasis in the human body. Integration, which is the biological basis of physiology, is achieved through communication between the many overlapping functions of the human body's systems, which takes place through electrical and chemical means. Much of the basis of our knowledge of human physiology has been provided by animal experiments. Because of the close relationship between structure and function, studies in human physiology and anatomy seek to understand the mechanisms that help the human body function. The series on human physiology deals with the various mechanisms of interaction between the various organs, nerves, and cells in the human body.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/12.jpg",hasOnlineFirst:!0,hasPublishedBooks:!0,annualVolume:11408,editor:{id:"195829",title:"Prof.",name:"Kunihiro",middleName:null,surname:"Sakuma",slug:"kunihiro-sakuma",fullName:"Kunihiro Sakuma",profilePictureURL:"https://mts.intechopen.com/storage/users/195829/images/system/195829.jpg",biography:"Professor Kunihiro Sakuma, Ph.D., currently works in the Institute for Liberal Arts at the Tokyo Institute of Technology. He is a physiologist working in the field of skeletal muscle. He was awarded his sports science diploma in 1995 by the University of Tsukuba and began his scientific work at the Department of Physiology, Aichi Human Service Center, focusing on the molecular mechanism of congenital muscular dystrophy and normal muscle regeneration. His interest later turned to the molecular mechanism and attenuating strategy of sarcopenia (age-related muscle atrophy). His opinion is to attenuate sarcopenia by improving autophagic defects using nutrient- and pharmaceutical-based treatments.",institutionString:null,institution:{name:"Tokyo Institute of Technology",institutionURL:null,country:{name:"Japan"}}},editorTwo:null,editorThree:{id:"331519",title:"Dr.",name:"Kotomi",middleName:null,surname:"Sakai",slug:"kotomi-sakai",fullName:"Kotomi Sakai",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000031QtFXQA0/Profile_Picture_1637053227318",biography:"Senior researcher Kotomi Sakai, Ph.D., MPH, works at the Research Organization of Science and Technology in Ritsumeikan University. She is a researcher in the geriatric rehabilitation and public health field. She received Ph.D. from Nihon University and MPH from St.Luke’s International University. Her main research interest is sarcopenia in older adults, especially its association with nutritional status. Additionally, to understand how to maintain and improve physical function in older adults, to conduct studies about the mechanism of sarcopenia and determine when possible interventions are needed.",institutionString:null,institution:{name:"Ritsumeikan University",institutionURL:null,country:{name:"Japan"}}},series:{id:"10",title:"Physiology",doi:"10.5772/intechopen.72796",issn:"2631-8261"},editorialBoard:[{id:"213786",title:"Dr.",name:"Henrique P.",middleName:null,surname:"Neiva",slug:"henrique-p.-neiva",fullName:"Henrique P. Neiva",profilePictureURL:"https://mts.intechopen.com/storage/users/213786/images/system/213786.png",institutionString:null,institution:{name:"University of Beira Interior",institutionURL:null,country:{name:"Portugal"}}},{id:"39275",title:"Prof.",name:"Herbert Ryan",middleName:null,surname:"Marini",slug:"herbert-ryan-marini",fullName:"Herbert Ryan Marini",profilePictureURL:"https://mts.intechopen.com/storage/users/39275/images/9459_n.jpg",institutionString:null,institution:{name:"University of Messina",institutionURL:null,country:{name:"Italy"}}},{id:"196218",title:"Dr.",name:"Pasquale",middleName:null,surname:"Cianci",slug:"pasquale-cianci",fullName:"Pasquale Cianci",profilePictureURL:"https://mts.intechopen.com/storage/users/196218/images/system/196218.png",institutionString:null,institution:{name:"University of Foggia",institutionURL:null,country:{name:"Italy"}}}]},onlineFirstChapters:{paginationCount:5,paginationItems:[{id:"81576",title:"Carotenoids in Thermal Adaptation of Plants and Animals",doi:"10.5772/intechopen.104537",signatures:"Ivan M. Petyaev",slug:"carotenoids-in-thermal-adaptation-of-plants-and-animals",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Ivan",surname:"Petyaev"}],book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81358",title:"New Insights on Carotenoid Production by Gordonia alkanivorans Strain 1B",doi:"10.5772/intechopen.103919",signatures:"Tiago P. Silva, Susana M. Paixão, Ana S. Fernandes, José C. Roseiro and Luís Alves",slug:"new-insights-on-carotenoid-production-by-gordonia-alkanivorans-strain-1b",totalDownloads:13,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81246",title:"Role of Carotenoids in Cardiovascular Disease",doi:"10.5772/intechopen.102750",signatures:"Arslan Ahmad, Sakhawat Riaz, Muhammad Shahzaib Nadeem, Umber Mubeen and Khadija Maham",slug:"role-of-carotenoids-in-cardiovascular-disease",totalDownloads:26,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81159",title:"Potential of Carotenoids from Fresh Tomatoes and Their Availability in Processed Tomato-Based Products",doi:"10.5772/intechopen.103933",signatures:"Rose Daphnee Ngameni Tchonkouang, Maria Dulce Carlos Antunes and Maria Margarida Cortês Vieira",slug:"potential-of-carotenoids-from-fresh-tomatoes-and-their-availability-in-processed-tomato-based-produc",totalDownloads:18,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"80902",title:"Computational Chemistry Study of Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates as Therapeutic Drugs",doi:"10.5772/intechopen.103130",signatures:"Norma Flores-Holguín, Juan Frau and Daniel Glossman-Mitnik",slug:"computational-chemistry-study-of-natural-apocarotenoids-and-their-synthetic-glycopeptide-conjugates-",totalDownloads:22,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Norma",surname:"Flores-Holguín"},{name:"Daniel",surname:"Glossman-Mitnik"},{name:"Juan",surname:"Frau"}],book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}}]},publishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"10843",title:"Persistent Organic Pollutants (POPs)",subtitle:"Monitoring, Impact and Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10843.jpg",slug:"persistent-organic-pollutants-pops-monitoring-impact-and-treatment",publishedDate:"April 13th 2022",editedByType:"Edited by",bookSignature:"Mohamed Nageeb Rashed",hash:"f5b1589f0a990b6114fef2dadc735dd9",volumeInSeries:1,fullTitle:"Persistent Organic Pollutants (POPs) - Monitoring, Impact and Treatment",editors:[{id:"63465",title:"Prof.",name:"Mohamed Nageeb",middleName:null,surname:"Rashed",slug:"mohamed-nageeb-rashed",fullName:"Mohamed Nageeb Rashed",profilePictureURL:"https://mts.intechopen.com/storage/users/63465/images/system/63465.gif",institutionString:null,institution:{name:"Aswan University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.jpg",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:8,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:98,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:286,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:9,numberOfPublishedChapters:101,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:11,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"4",title:"Fungal Infectious Diseases",scope:"Fungi are ubiquitous and there are almost no non-pathogenic fungi. Fungal infectious illness prevalence and prognosis are determined by the exposure between fungi and host, host immunological state, fungal virulence, and early and accurate diagnosis and treatment. \r\nPatients with both congenital and acquired immunodeficiency are more likely to be infected with opportunistic mycosis. Fungal infectious disease outbreaks are common during the post- disaster rebuilding era, which is characterised by high population density, migration, and poor health and medical conditions.\r\nSystemic or local fungal infection is mainly associated with the fungi directly inhaled or inoculated in the environment during the disaster. The most common fungal infection pathways are human to human (anthropophilic), animal to human (zoophilic), and environment to human (soilophile). Diseases are common as a result of widespread exposure to pathogenic fungus dispersed into the environment. \r\nFungi that are both common and emerging are intertwined. In Southeast Asia, for example, Talaromyces marneffei is an important pathogenic thermally dimorphic fungus that causes systemic mycosis. Widespread fungal infections with complicated and variable clinical manifestations, such as Candida auris infection resistant to several antifungal medicines, Covid-19 associated with Trichoderma, and terbinafine resistant dermatophytosis in India, are among the most serious disorders. \r\nInappropriate local or systemic use of glucocorticoids, as well as their immunosuppressive effects, may lead to changes in fungal infection spectrum and clinical characteristics. Hematogenous candidiasis is a worrisome issue that affects people all over the world, particularly ICU patients. CARD9 deficiency and fungal infection have been major issues in recent years. Invasive aspergillosis is associated with a significant death rate. Special attention should be given to endemic fungal infections, identification of important clinical fungal infections advanced in yeasts, filamentous fungal infections, skin mycobiome and fungal genomes, and immunity to fungal infections.\r\nIn addition, endemic fungal diseases or uncommon fungal infections caused by Mucor irregularis, dermatophytosis, Malassezia, cryptococcosis, chromoblastomycosis, coccidiosis, blastomycosis, histoplasmosis, sporotrichosis, and other fungi, should be monitored. \r\nThis topic includes the research progress on the etiology and pathogenesis of fungal infections, new methods of isolation and identification, rapid detection, drug sensitivity testing, new antifungal drugs, schemes and case series reports. It will provide significant opportunities and support for scientists, clinical doctors, mycologists, antifungal drug researchers, public health practitioners, and epidemiologists from all over the world to share new research, ideas and solutions to promote the development and progress of medical mycology.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/4.jpg",keywords:"Emerging Fungal Pathogens, Invasive Infections, Epidemiology, Cell Membrane, Fungal Virulence, Diagnosis, Treatment"},{id:"5",title:"Parasitic Infectious Diseases",scope:"Parasitic diseases have evolved alongside their human hosts. In many cases, these diseases have adapted so well that they have developed efficient resilience methods in the human host and can live in the host for years. Others, particularly some blood parasites, can cause very acute diseases and are responsible for millions of deaths yearly. Many parasitic diseases are classified as neglected tropical diseases because they have received minimal funding over recent years and, in many cases, are under-reported despite the critical role they play in morbidity and mortality among human and animal hosts. The current topic, Parasitic Infectious Diseases, in the Infectious Diseases Series aims to publish studies on the systematics, epidemiology, molecular biology, genomics, pathogenesis, genetics, and clinical significance of parasitic diseases from blood borne to intestinal parasites as well as zoonotic parasites. We hope to cover all aspects of parasitic diseases to provide current and relevant research data on these very important diseases. In the current atmosphere of the Coronavirus pandemic, communities around the world, particularly those in different underdeveloped areas, are faced with the growing challenges of the high burden of parasitic diseases. At the same time, they are faced with the Covid-19 pandemic leading to what some authors have called potential syndemics that might worsen the outcome of such infections. Therefore, it is important to conduct studies that examine parasitic infections in the context of the coronavirus pandemic for the benefit of all communities to help foster more informed decisions for the betterment of human and animal health.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/5.jpg",keywords:"Blood Borne Parasites, Intestinal Parasites, Protozoa, Helminths, Arthropods, Water Born Parasites, Epidemiology, Molecular Biology, Systematics, Genomics, Proteomics, Ecology"},{id:"6",title:"Viral Infectious Diseases",scope:"The Viral Infectious Diseases Book Series aims to provide a comprehensive overview of recent research trends and discoveries in various viral infectious diseases emerging around the globe. The emergence of any viral disease is hard to anticipate, which often contributes to death. A viral disease can be defined as an infectious disease that has recently appeared within a population or exists in nature with the rapid expansion of incident or geographic range. This series will focus on various crucial factors related to emerging viral infectious diseases, including epidemiology, pathogenesis, host immune response, clinical manifestations, diagnosis, treatment, and clinical recommendations for managing viral infectious diseases, highlighting the recent issues with future directions for effective therapeutic strategies.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/6.jpg",keywords:"Novel Viruses, Virus Transmission, Virus Evolution, Molecular Virology, Control and Prevention, Virus-host Interaction"}],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"7",title:"Biomedical Engineering",doi:"10.5772/intechopen.71985",issn:"2631-5343",scope:"Biomedical Engineering is one of the fastest-growing interdisciplinary branches of science and industry. The combination of electronics and computer science with biology and medicine has improved patient diagnosis, reduced rehabilitation time, and helped to facilitate a better quality of life. Nowadays, all medical imaging devices, medical instruments, or new laboratory techniques result from the cooperation of specialists in various fields. The series of Biomedical Engineering books covers such areas of knowledge as chemistry, physics, electronics, medicine, and biology. This series is intended for doctors, engineers, and scientists involved in biomedical engineering or those wanting to start working in this field.",coverUrl:"https://cdn.intechopen.com/series/covers/7.jpg",latestPublicationDate:"May 7th, 2022",hasOnlineFirst:!0,numberOfOpenTopics:3,numberOfPublishedChapters:96,numberOfPublishedBooks:12,editor:{id:"50150",title:"Prof.",name:"Robert",middleName:null,surname:"Koprowski",fullName:"Robert Koprowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTYNQA4/Profile_Picture_1630478535317",biography:"Robert Koprowski, MD (1997), PhD (2003), Habilitation (2015), is an employee of the University of Silesia, Poland, Institute of Computer Science, Department of Biomedical Computer Systems. For 20 years, he has studied the analysis and processing of biomedical images, emphasizing the full automation of measurement for a large inter-individual variability of patients. Dr. Koprowski has authored more than a hundred research papers with dozens in impact factor (IF) journals and has authored or co-authored six books. Additionally, he is the author of several national and international patents in the field of biomedical devices and imaging. Since 2011, he has been a reviewer of grants and projects (including EU projects) in biomedical engineering.",institutionString:null,institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}},subseries:[{id:"7",title:"Bioinformatics and Medical Informatics",keywords:"Biomedical Data, Drug Discovery, Clinical Diagnostics, Decoding Human Genome, AI in Personalized Medicine, Disease-prevention Strategies, Big Data Analysis in Medicine",scope:"Bioinformatics aims to help understand the functioning of the mechanisms of living organisms through the construction and use of quantitative tools. The applications of this research cover many related fields, such as biotechnology and medicine, where, for example, Bioinformatics contributes to faster drug design, DNA analysis in forensics, and DNA sequence analysis in the field of personalized medicine. Personalized medicine is a type of medical care in which treatment is customized individually for each patient. Personalized medicine enables more effective therapy, reduces the costs of therapy and clinical trials, and also minimizes the risk of side effects. Nevertheless, advances in personalized medicine would not have been possible without bioinformatics, which can analyze the human genome and other vast amounts of biomedical data, especially in genetics. The rapid growth of information technology enabled the development of new tools to decode human genomes, large-scale studies of genetic variations and medical informatics. The considerable development of technology, including the computing power of computers, is also conducive to the development of bioinformatics, including personalized medicine. In an era of rapidly growing data volumes and ever lower costs of generating, storing and computing data, personalized medicine holds great promises. Modern computational methods used as bioinformatics tools can integrate multi-scale, multi-modal and longitudinal patient data to create even more effective and safer therapy and disease prevention methods. Main aspects of the topic are: Applying bioinformatics in drug discovery and development; Bioinformatics in clinical diagnostics (genetic variants that act as markers for a condition or a disease); Blockchain and Artificial Intelligence/Machine Learning in personalized medicine; Customize disease-prevention strategies in personalized medicine; Big data analysis in personalized medicine; Translating stratification algorithms into clinical practice of personalized medicine.",annualVolume:11403,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/7.jpg",editor:{id:"351533",title:"Dr.",name:"Slawomir",middleName:null,surname:"Wilczynski",fullName:"Slawomir Wilczynski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035U1loQAC/Profile_Picture_1630074514792",institutionString:null,institution:{name:"Medical University of Silesia",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"5886",title:"Dr.",name:"Alexandros",middleName:"T.",surname:"Tzallas",fullName:"Alexandros Tzallas",profilePictureURL:"https://mts.intechopen.com/storage/users/5886/images/system/5886.png",institutionString:"University of Ioannina, Greece & Imperial College London",institution:{name:"University of Ioannina",institutionURL:null,country:{name:"Greece"}}},{id:"257388",title:"Distinguished Prof.",name:"Lulu",middleName:null,surname:"Wang",fullName:"Lulu Wang",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRX6kQAG/Profile_Picture_1630329584194",institutionString:null,institution:{name:"Shenzhen Technology University",institutionURL:null,country:{name:"China"}}},{id:"225387",title:"Prof.",name:"Reda",middleName:"R.",surname:"Gharieb",fullName:"Reda Gharieb",profilePictureURL:"https://mts.intechopen.com/storage/users/225387/images/system/225387.jpg",institutionString:"Assiut University",institution:{name:"Assiut University",institutionURL:null,country:{name:"Egypt"}}}]},{id:"8",title:"Bioinspired Technology and Biomechanics",keywords:"Bioinspired Systems, Biomechanics, Assistive Technology, Rehabilitation",scope:'Bioinspired technologies take advantage of understanding the actual biological system to provide solutions to problems in several areas. Recently, bioinspired systems have been successfully employing biomechanics to develop and improve assistive technology and rehabilitation devices. The research topic "Bioinspired Technology and Biomechanics" welcomes studies reporting recent advances in bioinspired technologies that contribute to individuals\' health, inclusion, and rehabilitation. Possible contributions can address (but are not limited to) the following research topics: Bioinspired design and control of exoskeletons, orthoses, and prostheses; Experimental evaluation of the effect of assistive devices (e.g., influence on gait, balance, and neuromuscular system); Bioinspired technologies for rehabilitation, including clinical studies reporting evaluations; Application of neuromuscular and biomechanical models to the development of bioinspired technology.',annualVolume:11404,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/8.jpg",editor:{id:"144937",title:"Prof.",name:"Adriano",middleName:"De Oliveira",surname:"Andrade",fullName:"Adriano Andrade",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRC8QQAW/Profile_Picture_1625219101815",institutionString:null,institution:{name:"Federal University of Uberlândia",institutionURL:null,country:{name:"Brazil"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"49517",title:"Prof.",name:"Hitoshi",middleName:null,surname:"Tsunashima",fullName:"Hitoshi Tsunashima",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTP4QAO/Profile_Picture_1625819726528",institutionString:null,institution:{name:"Nihon University",institutionURL:null,country:{name:"Japan"}}},{id:"425354",title:"Dr.",name:"Marcus",middleName:"Fraga",surname:"Vieira",fullName:"Marcus Vieira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003BJSgIQAX/Profile_Picture_1627904687309",institutionString:null,institution:{name:"Universidade Federal de Goiás",institutionURL:null,country:{name:"Brazil"}}},{id:"196746",title:"Dr.",name:"Ramana",middleName:null,surname:"Vinjamuri",fullName:"Ramana Vinjamuri",profilePictureURL:"https://mts.intechopen.com/storage/users/196746/images/system/196746.jpeg",institutionString:"University of Maryland, Baltimore County",institution:{name:"University of Maryland, Baltimore County",institutionURL:null,country:{name:"United States of America"}}}]},{id:"9",title:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",keywords:"Biotechnology, Biosensors, Biomaterials, Tissue Engineering",scope:"The Biotechnology - Biosensors, Biomaterials and Tissue Engineering topic within the Biomedical Engineering Series aims to rapidly publish contributions on all aspects of biotechnology, biosensors, biomaterial and tissue engineering. We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics can include but are not limited to: Biotechnology such as biotechnological products and process engineering; Biotechnologically relevant enzymes and proteins; Bioenergy and biofuels; Applied genetics and molecular biotechnology; Genomics, transcriptomics, proteomics; Applied microbial and cell physiology; Environmental biotechnology; Methods and protocols. Moreover, topics in biosensor technology, like sensors that incorporate enzymes, antibodies, nucleic acids, whole cells, tissues and organelles, and other biological or biologically inspired components will be considered, and topics exploring transducers, including those based on electrochemical and optical piezoelectric, thermal, magnetic, and micromechanical elements. Chapters exploring biomaterial approaches such as polymer synthesis and characterization, drug and gene vector design, biocompatibility, immunology and toxicology, and self-assembly at the nanoscale, are welcome. Finally, the tissue engineering subcategory will support topics such as the fundamentals of stem cells and progenitor cells and their proliferation, differentiation, bioreactors for three-dimensional culture and studies of phenotypic changes, stem and progenitor cells, both short and long term, ex vivo and in vivo implantation both in preclinical models and also in clinical trials.",annualVolume:11405,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/9.jpg",editor:{id:"126286",title:"Dr.",name:"Luis",middleName:"Jesús",surname:"Villarreal-Gómez",fullName:"Luis Villarreal-Gómez",profilePictureURL:"https://mts.intechopen.com/storage/users/126286/images/system/126286.jpg",institutionString:null,institution:{name:"Autonomous University of Baja California",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"35539",title:"Dr.",name:"Cecilia",middleName:null,surname:"Cristea",fullName:"Cecilia Cristea",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYQ65QAG/Profile_Picture_1621007741527",institutionString:null,institution:{name:"Iuliu Hațieganu University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"40735",title:"Dr.",name:"Gil",middleName:"Alberto Batista",surname:"Gonçalves",fullName:"Gil Gonçalves",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYRLGQA4/Profile_Picture_1628492612759",institutionString:null,institution:{name:"University of Aveiro",institutionURL:null,country:{name:"Portugal"}}},{id:"211725",title:"Associate Prof.",name:"Johann F.",middleName:null,surname:"Osma",fullName:"Johann F. Osma",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDv7QAG/Profile_Picture_1626602531691",institutionString:null,institution:{name:"Universidad de Los Andes",institutionURL:null,country:{name:"Colombia"}}},{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",fullName:"Mani T. Valarmathi",profilePictureURL:"https://mts.intechopen.com/storage/users/69697/images/system/69697.jpg",institutionString:"Religen Inc. | A Life Science Company, United States of America",institution:null},{id:"205081",title:"Dr.",name:"Marco",middleName:"Vinícius",surname:"Chaud",fullName:"Marco Chaud",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDGeQAO/Profile_Picture_1622624307737",institutionString:null,institution:{name:"Universidade de Sorocaba",institutionURL:null,country:{name:"Brazil"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"profile.detail",path:"/profiles/208595",hash:"",query:{},params:{id:"208595"},fullPath:"/profiles/208595",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()